var title_f2_9_2192="Melioidosis septicemia";
var content_f2_9_2192=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F66663&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F66663&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chest radiograph of melioidosis with fulminant septicemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph in a patient with a fulminant presentation of melioidosis with septicemia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bart Currie, FRACP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2192=[""].join("\n");
var outline_f2_9_2192=null;
var title_f2_9_2193="Blount disease radiograph";
var content_f2_9_2193=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blount disease radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 381px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Radiograph of a patient with bilateral Blount disease showing characteristic medial beaking and downward slope of the proximal tibia metaphysic (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott Rosenfeld, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2193=[""].join("\n");
var outline_f2_9_2193=null;
var title_f2_9_2194="Overview T cell activation";
var content_f2_9_2194=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60525&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60525&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 617px\">",
"   <div class=\"ttl\">",
"    Overview of T cell activation and proliferation showing the site of action of available and experimental immunomodulatory agents",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 597px; height: 390px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Vierling, JM. Clinical Use of Immunosuppressive Drugs to Control the Immune Response. In: Liver Immunology: Principles and Practice, Gershwin, ME, Vierling, JM, Manns, MP (Eds), Humana Press, Totowa 2007. Copyright &copy;2007 Springer-Verlag.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2194=[""].join("\n");
var outline_f2_9_2194=null;
var title_f2_9_2195="CXR and chest CT scan showing pericardial and pleural effusions";
var content_f2_9_2195=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chest radiograph (CXR, panel A) and computed tomography (CT, panel B) showing pericardial and pleural effusions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 323px; height: 495px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Chest radiograph in a patient with concomitant malignant pericardial and malignant pleural effusions from metastatic breast cancer. B) CT scan of the chest in a patient with concomitant malignant pericardial and malignant pleural effusions from metastatic breast cancer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of: DeCamp MM, Gangadharan SP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2195=[""].join("\n");
var outline_f2_9_2195=null;
var title_f2_9_2196="Spinosad: Patient drug information";
var content_f2_9_2196=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Spinosad: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/55/17267?source=see_link\">",
"     see \"Spinosad: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/54/2915?source=see_link\">",
"     see \"Spinosad: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F11404426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Natroba&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F11561844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691871",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat head lice.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F11561773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3069420",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to spinosad or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F11561775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F11561849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698317",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Scalp irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F11561777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F11561846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696964",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to use carefully.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3069424",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your scalp and hair only. Keep out of your mouth, nose, ears, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694638",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cover eyes and face with a towel.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695621",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694807",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not wet hair before putting on lotion.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694453",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Coat hair and scalp.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695283",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not cover head while lotion is on hair.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695285",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Leave on for 10 minutes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3069425",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rinse fully with warm water. You may use shampoo after all of the lotion is rinsed out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3069426",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may use a special nit comb or tweezers to get rid of dead nits (lice eggs) from hair, but you do not have to get rid of the nits. The lotion kills the nits too.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3069427",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash all hair combs, brushes, hair clips, bedding, towels, and recently worn clothes in hot water or have them dry cleaned.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F11561774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F11561850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Do not freeze.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F11561778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16463 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-346F7DA307-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2196=[""].join("\n");
var outline_f2_9_2196=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11404426\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11561844\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11561773\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11561775\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11561849\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11561777\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11561846\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11561774\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11561850\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11561778\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/55/17267?source=related_link\">",
"      Spinosad: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/54/2915?source=related_link\">",
"      Spinosad: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_9_2197="Dantrolene: Patient drug information";
var content_f2_9_2197=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dantrolene: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/22/22887?source=see_link\">",
"     see \"Dantrolene: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/20/43335?source=see_link\">",
"     see \"Dantrolene: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F156723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dantrium&reg;;",
"     </li>",
"     <li>",
"      Revonto&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F156724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dantrium&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700726",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause liver problems when high doses are used. The chance is greatest in women, patients older than 35 years of age, and patients taking other drugs. Your doctor will be watching your liver tests. Using the smallest dose as you can lowers the chance of liver problems. If your signs are not better after 45 days of use, talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691274",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to calm muscles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2733435",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat very high body temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701890",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dantrolene or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701006",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If spasticity helps you keep your balance.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699024",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is used with rest, PT (physical therapy), pain drugs, and other therapies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695944",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12354 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-4F9416D058-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2197=[""].join("\n");
var outline_f2_9_2197=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156723\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F156724\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027116\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027118\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027117\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027122\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027123\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027125\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027120\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027121\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027126\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027127\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?22/22/22887?source=related_link\">",
"      Dantrolene: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/20/43335?source=related_link\">",
"      Dantrolene: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_9_2198="Classification carcinoid tumors by embryonic derivation";
var content_f2_9_2198=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F83185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F83185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 551px\">",
"   <div class=\"ttl\">",
"    Anatomic location of carcinoid tumors based upon embryonic divisions of the alimentary tract",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 531px; height: 667px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2198=[""].join("\n");
var outline_f2_9_2198=null;
var title_f2_9_2199="Percutaneous liver biopsy - medium power";
var content_f2_9_2199=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Percutaneous liver biopsy in a comatose 17-year-old woman who presented with elevated ALT and AST levels (medium power, Gomori trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Almost all of the hepatocytes are vacuolated, and nuclei are at the center of the hepatocytes. There is no inflammation or obvious liver cell necrosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2199=[""].join("\n");
var outline_f2_9_2199=null;
var title_f2_9_2200="Diagnostic approach, differential diagnosis, and treatment of a small renal mass";
var content_f2_9_2200=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic approach, differential diagnosis, and treatment of a small renal mass",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/9/2200/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2200/contributors\">",
"     Susanna I Lee, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2200/contributors\">",
"     Shauna Duigenan, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/9/2200/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2200/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2200/contributors\">",
"     Michael B Atkins, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/9/2200/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2200/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/9/2200/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The detection of small renal masses has increased due to the increased use of imaging tests, such as ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI), performed for unrelated indications [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/1\">",
"     1",
"    </a>",
"    ]. The majority of renal lesions can be characterized as benign simple cysts, which would require no further work-up. However, completely solid or mixed solid and cystic renal lesions that enhance with contrast are likely to be malignant and warrant further evaluation and management [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The initial evaluation, differential diagnosis, diagnostic approach, and treatment of small renal masses will be reviewed here. The evaluation of renal cell carcinoma and renal cysts is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/32/35336?source=see_link\">",
"     \"Clinical manifestations, evaluation, and staging of renal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27704?source=see_link\">",
"     \"Simple and complex renal cysts in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H424384634\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A renal lesion measuring &lt;4 cm in largest dimension that demonstrates contrast enhancement on abdominal imaging meets criteria for a small renal mass [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/3\">",
"     3",
"    </a>",
"    ]. These lesions are classified as either solid (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef87863 \" href=\"UTD.htm?7/30/7650\">",
"     image 1",
"    </a>",
"    ) or complex cystic (Bosniak class III or class IV [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/4\">",
"     4",
"    </a>",
"    ]) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef87864 \" href=\"UTD.htm?41/23/42358\">",
"     image 2",
"    </a>",
"    ) based on their imaging appearance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27704?source=see_link\">",
"     \"Simple and complex renal cysts in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H641324786\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small renal masses are concerning because of the risk of renal cell carcinoma (RCC); this risk increases as the mass gets larger (",
"    <a class=\"graphic graphic_table graphicRef87865 \" href=\"UTD.htm?26/17/26907\">",
"     table 1",
"    </a>",
"    ). Over three-quarters of small renal masses are malignant [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/4\">",
"     4",
"    </a>",
"    ], and among malignant masses, larger size correlates with a higher pathologic grade [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/5\">",
"     5",
"    </a>",
"    ]. However, almost 70 percent of masses &lt;2 cm are malignant [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no clinical or radiographic features of solid or complex cystic masses that accurately predict which lesions will grow; in addition, there are no accurate features that predict histologic diagnosis, risk of malignancy, or prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. Growth rates also do not reliably predict the biologic behavior of a mass [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/7\">",
"     7",
"    </a>",
"    ]. Representative studies that illustrate this point include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a 2006 meta-analysis of 10 published reports (n=234 lesions not immediately resected), the mean lesion size at presentation was 2.6 cm (range 1.7 to 4.1 cm) and the mean growth rate was 0.3 cm per year [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/7\">",
"       7",
"      </a>",
"      ]. Of 131 lesions that were subsequently resected, 92 percent were RCC. Despite the high incidence of malignancy, only three patients (one percent) developed metastatic disease during the follow-up period.",
"     </li>",
"     <li>",
"      A separate study compared the clinical characteristics of small renal masses that showed zero growth (n=35) to those that grew (n=71) during active surveillance [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/8\">",
"       8",
"      </a>",
"      ]. There were no differences in patient age, lesion size,",
"      <span class=\"nowrap\">",
"       solid/cystic",
"      </span>",
"      appearance, or the incidental detection rate. Although fewer lesions showing zero growth were resected (6 of 35 compared to 36 of 71 that did grow), the overall incidence of malignancy was similar (83 and 89 percent, respectively).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20510064\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients are diagnosed with a small renal mass after undergoing imaging (CT, MRI, or US) for an unrelated reason. To further evaluate these lesions, a protocol-specified dedicated renal CT or MRI exam is required. (See",
"    <a class=\"local\" href=\"#H20510122\">",
"     'Dedicated renal imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, an incidental lesion &lt;1 cm is unlikely to be further characterized by additional imaging or biopsy, and these patients should be offered surveillance. This size cut-off is accepted by most radiologists because imaging protocols (using computed tomography [CT] or magnetic resonance imaging [MRI]) obtain images at 5 mm slice thickness. In addition, lesions &ge; 1.5 cm have a reasonable chance of being diagnosed by biopsy or additional diagnostic work-up.",
"   </p>",
"   <p>",
"    The approach to diagnosis and management of small renal masses is summarized in an algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef87866 \" href=\"UTD.htm?0/17/287\">",
"     algorithm 1",
"    </a>",
"    ) and is discussed further below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20510122\">",
"    <span class=\"h2\">",
"     Dedicated renal imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal imaging to assess an incidental renal lesion involves a dedicated renal CT or MRI done without and then with intravenous contrast administration. The available data suggest that both modalities perform with comparable diagnostic accuracy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/11\">",
"     11",
"    </a>",
"    ]. However, if a cystic component is present on the original imaging evaluation, a dedicated renal CT scan may be the preferred imaging in order to characterize these lesions using Bosniak criteria (which are based on findings on CT).",
"   </p>",
"   <p>",
"    Ultimately, the choice between CT and MRI to work up a complicated cystic or solid renal mass should be based on the locally available scanner and radiologist expertise. (See",
"    <a class=\"local\" href=\"#H705510626\">",
"     'Imaging characteristics'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Other specific features that may be helpful in determining which imaging to use in individual patients include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Features that favor CT include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Rapid image acquisition, which might be a consideration for patients with claustrophobia or other factors that preclude the ability to lie still for an MRI, which usually takes 20 to 30 minutes.",
"     </li>",
"     <li>",
"      Compatibility with metallic medical implants (eg, pacemakers and orthopedic prostheses).",
"     </li>",
"     <li>",
"      Ability to obtain high-resolution quantitative assessment of enhancement using Hounsfield unit measurements.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Features that favor MRI include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      No exposure to radiation, which may be a consideration for younger patients (age &lt;35 years).",
"     </li>",
"     <li>",
"      Use of gadolinium contrast, which has a much lower risk of an allergic reaction compared to intravenous contrast used with CT.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of note, while multiphase contrast-enhanced MR imaging can differentiate the various types of RCC (eg, clear cell, papillary, or chromophobe) with excellent reader agreement, it is not able to differentiate between clear cell RCC and oncocytomas [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/12\">",
"     12",
"    </a>",
"    ]. Therefore, it has a limited role in the diagnostic evaluation of a small renal mass.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H705510626\">",
"    <span class=\"h3\">",
"     Imaging characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following imaging-based characteristics can be used to describe a small renal mass:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Enhancement &mdash; Enhancement is characterized on CT as an increase in signal &gt;20 Hounsfield units after intravenous contrast administration [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/13\">",
"       13",
"      </a>",
"      ]. Enhancement can also be demonstrated on MRI by subtracting the signal intensity on post-contrast images from the pre-contrast images [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Characteristics of a cystic component &mdash; Cystic lesions are characterized by the Bosniak criteria, which are defined based on CT findings [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/4\">",
"       4",
"      </a>",
"      ]. Although not yet validated for reader agreement or generalizability [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/15\">",
"       15",
"      </a>",
"      ], these criteria have been widely adopted to classify renal cysts as definitely benign (type I and II), likely benign (type IIF), or likely malignant (type III and IV). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27704?source=see_link&amp;anchor=H2#H2\">",
"       \"Simple and complex renal cysts in adults\", section on 'Bosniak classification of renal cysts'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Presence of fat &mdash; The presence of fat on CT is characterized as a density measured by Hounsfield units, which is less than water or soft tissue (ie, -10 Hounsfield units) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50146 \" href=\"UTD.htm?34/57/35743\">",
"       image 3",
"      </a>",
"      ). It is detected on MRI by a loss of high T1 signal on fat-suppression sequences [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20510149\">",
"    <span class=\"h2\">",
"     Percutaneous biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous needle biopsy of a small renal mass is indicated if there is a high index of suspicion for:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A metastatic lesion to the kidney &nbsp;",
"     </li>",
"     <li>",
"      A focal kidney infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A biopsy can also be used to confirm a diagnosis of RCC is indicated in patients who are not surgical candidates (eg, due to comorbidities, the presence of unresectable disease, or a lesion in a solitary kidney) in order to initiate appropriate medical treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/17\">",
"     17",
"    </a>",
"    ]. Furthermore, a biopsy can be performed in patients who are surgical candidates, if confirmation of malignancy is desired by the patient or the surgeon prior to the procedure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/1/21528?source=see_link\">",
"     \"Overview of the treatment of renal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A biopsy can render a definitive diagnosis for RCC and benign masses, including angiomyolipoma, metanephric adenoma, or focal infection. However, a diagnosis of oncocytoma, while reassuring, should be viewed with caution as chromophobe renal cell carcinoma can result in a similar appearance on needle biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/18\">",
"     18",
"    </a>",
"    ]. If the biopsy yields a nondiagnostic or a nonspecific result, a repeat biopsy is a reasonable option. However, in the absence of a definitive diagnosis, the mass should be managed as a RCC. (See",
"    <a class=\"local\" href=\"#H4159984\">",
"     'Management'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H191275486\">",
"    <span class=\"h2\">",
"     Procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biopsy is usually performed as an outpatient procedure under CT or ultrasound guidance with conscious sedation. Percutaneous biopsy is safe with a very low risk of clinically significant bleeding or seeding of the needle tract with malignant cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. The test demonstrates sensitivity and specificity of 80 to 92 percent and 83 to 100 percent, respectively, for the detection of cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/18,23,24\">",
"     18,23,24",
"    </a>",
"    ] and is especially helpful in differentiating RCC from a metastasis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H641325186\">",
"    <span class=\"h2\">",
"     Renal cell carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of small renal masses are renal cell carcinomas (RCCs) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/5\">",
"     5",
"    </a>",
"    ]. However, patients diagnosed with small RCCs are unlikely to have metastases at presentation or to develop metastases during follow-up. In a single-institution series of patients who underwent nephrectomy for pathologically confirmed RCC, only 1 of 781 patients with a primary RCC &lt;3 cm had a distant metastasis identified at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, only 1 of 720 with a primary &lt;3 cm and without metastasis at presentation subsequently developed metastatic disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/32/35336?source=see_link\">",
"     \"Clinical manifestations, evaluation, and staging of renal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H641325609\">",
"    <span class=\"h2\">",
"     Other primary renal tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to RCC, solid lesions may represent metastases from a primary tumor at another site or a benign renal lesion. In a single institution experience, 311 of 2675 surgically resected tumors were benign [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/26\">",
"     26",
"    </a>",
"    ]. These included oncocytoma (75 percent), angiomyolipoma (11 percent), and metanephric adenoma (3 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H641325391\">",
"    <span class=\"h3\">",
"     Oncocytoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oncocytomas typically appear on CT or MRI as a homogeneous, well-circumscribed solid mass containing a central scar [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/27\">",
"     27",
"    </a>",
"    ]. However, these features are not sufficiently specific to exclude renal cell carcinoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/52/18250?source=see_link&amp;anchor=H20#H20\">",
"     \"Epidemiology, pathology, and pathogenesis of renal cell carcinoma\", section on 'Oncocytomas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H641325398\">",
"    <span class=\"h3\">",
"     Angiomyolipoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiomyolipomas can be reliably distinguished on imaging as an enhancing mass that contains macroscopic fat and no calcifications (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50146 \" href=\"UTD.htm?34/57/35743\">",
"     image 3",
"    </a>",
"    ). Renal cell carcinoma, particularly the clear cell subtype, can contain microscopic fat, but this can reliably be distinguished from macroscopic fat on imaging. Small angiomyolipomas with minimal fat are difficult to characterize on imaging and generally require further evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20510064\">",
"     'Diagnostic evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    When renal angiomyolipomas are bilateral, patients have an 80 to 90 percent chance of having tuberous sclerosis. Patients with tuberous sclerosis also have an increased frequency of RCC, although malignancies are less common than with other hereditary syndromes such as von Hippel-Lindau syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43303?source=see_link\">",
"     \"Renal manifestations of tuberous sclerosis and renal angiomyolipoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=see_link\">",
"     \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22618?source=see_link\">",
"     \"Clinical features, diagnosis, and management of von Hippel-Lindau disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35910?source=see_link\">",
"     \"Hereditary kidney cancer syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H641325405\">",
"    <span class=\"h3\">",
"     Metanephric adenoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metanephric adenomas are rare benign lesions that are more common in women than men [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Although many cases are initially identified incidentally, some patients present with pain, hematuria, or a palpable mass. Metanephric adenomas are defined by a characteristic histology but may be difficult to distinguish from chromophilic (papillary) RCC or epithelial predominant Wilms tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/52/18250?source=see_link&amp;anchor=H18#H18\">",
"     \"Epidemiology, pathology, and pathogenesis of renal cell carcinoma\", section on 'Papillary carcinomas'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/12/2249?source=see_link&amp;anchor=H10#H10\">",
"     \"Presentation, diagnosis, and staging of Wilms tumor\", section on 'Pathology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H760206058\">",
"    <span class=\"h2\">",
"     Metastatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with a history of a non-renal cancer, a solitary lesion in the kidney may represent metastatic disease or a primary renal tumor. In a series of 2340 patients with a primary non-renal cancer, 36 (1.5 percent) had a renal lesion concomitantly diagnosed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/34\">",
"     34",
"    </a>",
"    ]. Of these, 21 (58 percent) were due to metastatic disease to the kidney; in the remaining 13 (42 percent), there was a concomitant RCC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Xanthogranulomatous pyelonephritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Xanthogranulomatous pyelonephritis is an unusual variant of chronic pyelonephritis. In two-thirds of cases, it is a complication of urinary obstruction from infected renal stones. Clues to the presence of xanthogranulomatous pyelonephritis include a history of urinary tract infections and the presence of pyuria and bacteriuria at presentation. CT can suggest this diagnosis by demonstrating an obstructing kidney stone and several rounded, low density areas corresponding to dilated calyces lined with necrotic xanthomatous tissue extending into the renal parenchyma (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70240 \" href=\"UTD.htm?41/36/42575\">",
"     image 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/26/16804?source=see_link\">",
"     \"Xanthogranulomatous pyelonephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4159984\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no singular approach to the management of small renal lesions. One approach to patients is described below and in an algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef87866 \" href=\"UTD.htm?0/17/287\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with a mass &lt;1 cm, we proceed with active surveillance. These patients should not pursue further studies at the time of presentation because they are not likely to be diagnostic. (See",
"      <a class=\"local\" href=\"#H20510064\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1313885206\">",
"       'Active surveillance'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      For patients with a renal mass &ge;1 to 4 cm, management depends on whether they are surgical candidates:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients who are surgical candidates who have a life expectancy of five years or longer, we proceed with surgery for a presumed renal cell carcinoma (RCC). (See",
"      <a class=\"local\" href=\"#H1313885190\">",
"       'Surgery'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      For patients who are not surgical candidates (including those with a life expectancy &lt;5 years), we proceed with a biopsy. If an RCC is detected, these patients may be candidates for thermal ablation. If the expertise to perform thermal ablation is not available, we proceed with active surveillance. Patients with an uninformative result following a biopsy and those who refuse biopsy should be treated for presumed RCC. (See",
"      <a class=\"local\" href=\"#H1313885206\">",
"       'Active surveillance'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H1313885199\">",
"       'Thermal ablation'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1313885190\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the patient with a small renal mass has a life expectancy of &gt;5 years and no risk factors that preclude surgery, we favor surgical resection. In most cases, we prefer nephron-sparing surgery or partial nephrectomy rather than a total nephrectomy because it allows for preservation of renal function. However, a total nephrectomy may be necessary for small masses centrally located within the renal hilum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5546?source=see_link&amp;anchor=H3#H3\">",
"     \"Surgical management of localized renal cell carcinoma\", section on 'Stage I and II disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1313885199\">",
"    <span class=\"h2\">",
"     Thermal ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;We reserve thermal ablation for patients with a small RCC who are not candidates for surgery. In addition, ablation is a treatment option for RCC arising in a patient post-partial nephrectomy, patients with a unilateral or transplanted kidney, or for patients at risk for multiple RCCs over their lifetime. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35910?source=see_link\">",
"     \"Hereditary kidney cancer syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ablation of a renal mass can be accomplished with either freezing (cryoablation) or heat (radiofrequency or microwave ablation). It is typically performed following a needle biopsy that confirms a malignant diagnosis. The procedure calls for a needle applicator to be placed under imaging guidance, using a percutaneous approach. It is typically carried out as an outpatient procedure under conscious sedation. After ablation, all patients should undergo surveillance to assess for residual or recurrent tumor that would require additional therapy. (See",
"    <a class=\"local\" href=\"#H1313885206\">",
"     'Active surveillance'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    While the initial experience with percutaneous thermal ablation demonstrates favorable short-term (ie, one to three years) outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/35-37\">",
"     35-37",
"    </a>",
"    ], evidence demonstrating long-term outcomes equivalent to partial nephrectomy is yet to be reported. Further discussion of ablation as a treatment for RCC is covered separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/44/26310?source=see_link\">",
"     \"Radiofrequency ablation and cryoablation for renal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1313885206\">",
"    <span class=\"h2\">",
"     Active surveillance",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, active surveillance is reserved for patients with a &lt;1 cm mass at initial diagnosis and in patients with a limited life expectancy who may be candidates for intervention if the tumor grows. However, it should be offered to patients with a biopsy-proven or presumed RCC who are not candidates for surgery if the expertise to perform a thermal ablation is not available. (See",
"    <a class=\"local\" href=\"#H1313885199\">",
"     'Thermal ablation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Active surveillance involves serial imaging with CT or MRI, although there are no data to inform the optimal surveillance strategy. We perform imaging at 6 and 12 months following initial diagnosis and then annually for five years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20510122\">",
"     'Dedicated renal imaging'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The safety of active surveillance was evaluated in a 2012 meta-analysis of 18 retrospective series with 23 to 39 months of followup [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2200/abstract/39\">",
"     39",
"    </a>",
"    ]. It concluded that surveillance is generally safe; only 3 of 286 patients (one percent) developed metastases. Compared to those without progression, factors significantly associated with disease progression included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased age (75 versus 67 years)",
"     </li>",
"     <li>",
"      Larger tumor dimension at presentation (4 versus 2 cm) or higher initial estimated tumor volume (66 versus 15 cm",
"      <sup>",
"       3",
"      </sup>",
"      )",
"     </li>",
"     <li>",
"      Higher rate of linear (0.8 versus 0.3 cm per year) or volumetric growth (27 versus 6 cm",
"      <sup>",
"       3",
"      </sup>",
"      per year)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidental detection of a small renal mass has increased, likely as a result of more frequent imaging performed for an unrelated reason or as part of an evaluation for other symptoms. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A renal lesion measuring &lt;4 cm in largest dimension that demonstrates contrast enhancement on abdominal imaging meets criteria for a small renal mass. (See",
"      <a class=\"local\" href=\"#H424384634\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The vast majority of small renal masses are renal cell carcinoma (RCC). However, up to 30 percent of lesions &lt;2 cm are benign. (See",
"      <a class=\"local\" href=\"#H641324786\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neither tumor size at diagnosis nor the growth rate is an accurate predictor of the presence of renal cell carcinoma. (See",
"      <a class=\"local\" href=\"#H641324786\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with an incidentally detected small renal mass, we recommend a dedicated renal CT or MRI as the first step in characterizing the lesion. (See",
"      <a class=\"local\" href=\"#H20510122\">",
"       'Dedicated renal imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Percutaneous biopsy is indicated in patients with masses suspected to be a metastasis, focal infection, and in patients in whom surgery is not being contemplated (eg, due to comorbidities, solitary kidney, or known unresectable disease). (See",
"      <a class=\"local\" href=\"#H20510149\">",
"       'Percutaneous biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a small renal mass &lt;1 cm in greatest dimension, we suggest active surveillance rather than surgical resection (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1313885206\">",
"       'Active surveillance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a small renal mass &ge;1 to 4 cm in size, have a life expectancy &gt;5 years, and are surgical candidates, we suggest surgical resection for a presumed RCC, rather than active surveillance or thermal ablation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1313885190\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a small renal mass &ge;1 to 4 cm and are not surgical candidates, a biopsy should be performed. Patients with a biopsy proven RCC and those in whom an RCC cannot be ruled-out are candidates for thermal ablation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If thermal ablation is not an option, then patients should be offered active surveillance. (See",
"      <a class=\"local\" href=\"#H1313885199\">",
"       'Thermal ablation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with an uninformative result following a biopsy and those patients with a small renal mass who decline biopsy should be treated for presumed RCC. (See",
"      <a class=\"local\" href=\"#H4159984\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/1\">",
"      Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281:1628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/2\">",
"      Millet I, Doyon FC, Hoa D, et al. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR Am J Roentgenol 2011; 197:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/3\">",
"      Volpe A, Panzarella T, Rendon RA, et al. The natural history of incidentally detected small renal masses. Cancer 2004; 100:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/4\">",
"      Bosniak MA. The current radiological approach to renal cysts. Radiology 1986; 158:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/5\">",
"      Schlomer B, Figenshau RS, Yan Y, et al. Pathological features of renal neoplasms classified by size and symptomatology. J Urol 2006; 176:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/6\">",
"      Akdogan B, Gudeloglu A, Inci K, et al. Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma. Clin Genitourin Cancer 2012; 10:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/7\">",
"      Chawla SN, Crispen PL, Hanlon AL, et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/8\">",
"      Kunkle DA, Crispen PL, Chen DY, et al. Enhancing renal masses with zero net growth during active surveillance. J Urol 2007; 177:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/9\">",
"      Pahernik S, Ziegler S, Roos F, et al. Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol 2007; 178:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/10\">",
"      Klatte T, Patard JJ, de Martino M, et al. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol 2008; 179:1719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/11\">",
"      Beer AJ, Dobritz M, Zantl N, et al. Comparison of 16-MDCT and MRI for characterization of kidney lesions. AJR Am J Roentgenol 2006; 186:1639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/12\">",
"      Vargas HA, Chaim J, Lefkowitz RA, et al. Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology 2012; 264:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/13\">",
"      Birnbaum BA, Hindman N, Lee J, Babb JS. Renal cyst pseudoenhancement: influence of multidetector CT reconstruction algorithm and scanner type in phantom model. Radiology 2007; 244:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/14\">",
"      Newatia A, Khatri G, Friedman B, Hines J. Subtraction imaging: applications for nonvascular abdominal MRI. AJR Am J Roentgenol 2007; 188:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/15\">",
"      Siegel CL, McFarland EG, Brink JA, et al. CT of cystic renal masses: analysis of diagnostic performance and interobserver variation. AJR Am J Roentgenol 1997; 169:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/16\">",
"      Yamashita Y, Ueno S, Makita O, et al. Hyperechoic renal tumors: anechoic rim and intratumoral cysts in US differentiation of renal cell carcinoma from angiomyolipoma. Radiology 1993; 188:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/17\">",
"      Barwari K, de la Rosette JJ, Laguna MP. The penetration of renal mass biopsy in daily practice: a survey among urologists. J Endourol 2012; 26:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/18\">",
"      Shannon BA, Cohen RJ, de Bruto H, Davies RJ. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol 2008; 180:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/19\">",
"      Lebret T, Poulain JE, Molinie V, et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 2007; 178:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/20\">",
"      Maturen KE, Nghiem HV, Caoili EM, et al. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol 2007; 188:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/21\">",
"      Wang R, Wolf JS Jr, Wood DP Jr, et al. Accuracy of percutaneous core biopsy in management of small renal masses. Urology 2009; 73:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/22\">",
"      Menogue SR, O'Brien BA, Brown AL, Cohen RJ. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention. BJU Int 2013; 111:E146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/23\">",
"      Volpe A, Kachura JR, Geddie WR, et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 2007; 178:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/24\">",
"      Rybicki FJ, Shu KM, Cibas ES, et al. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol 2003; 180:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/25\">",
"      Thompson RH, Hill JR, Babayev Y, et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol 2009; 182:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/26\">",
"      Thompson RH, Kurta JM, Kaag M, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol 2009; 181:2033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/27\">",
"      Lieber MM. Renal oncocytoma: prognosis and treatment. Eur Urol 1990; 18 Suppl 2:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/28\">",
"      Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 2004; 230:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/29\">",
"      Hafron J, Fogarty JD, Hoenig DM, et al. Imaging characteristics of minimal fat renal angiomyolipoma with histologic correlations. Urology 2005; 66:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/30\">",
"      van Baal JG, Smits NJ, Keeman JN, et al. The evolution of renal angiomyolipomas in patients with tuberous sclerosis. J Urol 1994; 152:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/31\">",
"      Jones EC, Pins M, Dickersin GR, Young RH. Metanephric adenoma of the kidney. A clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases. Am J Surg Pathol 1995; 19:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/32\">",
"      Davis CJ Jr, Barton JH, Sesterhenn IA, Mostofi FK. Metanephric adenoma. Clinicopathological study of fifty patients. Am J Surg Pathol 1995; 19:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/33\">",
"      Hartman DJ, Maclennan GT. Renal metanephric adenoma. J Urol 2007; 178:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/34\">",
"      Patel U, Ramachandran N, Halls J, et al. Synchronous renal masses in patients with a nonrenal malignancy: incidence of metastasis to the kidney versus primary renal neoplasia and differentiating features on CT. AJR Am J Roentgenol 2011; 197:W680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/35\">",
"      Gervais DA, McGovern FJ, Arellano RS, et al. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/36\">",
"      Zagoria RJ, Traver MA, Werle DM, et al. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007; 189:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/37\">",
"      Breen DJ, Rutherford EE, Stedman B, et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol 2007; 30:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/38\">",
"      Berland LL, Silverman SG, Gore RM, et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 2010; 7:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2200/abstract/39\">",
"      Smaldone MC, Kutikov A, Egleston BL, et al. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 2012; 118:997.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2970 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.1.191.153-863D5741FF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2200=[""].join("\n");
var outline_f2_9_2200=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H424384634\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H641324786\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20510064\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20510122\">",
"      Dedicated renal imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H705510626\">",
"      - Imaging characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20510149\">",
"      Percutaneous biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H191275486\">",
"      Procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H641325186\">",
"      Renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H641325609\">",
"      Other primary renal tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H641325391\">",
"      - Oncocytoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H641325398\">",
"      - Angiomyolipoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H641325405\">",
"      - Metanephric adenoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H760206058\">",
"      Metastatic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Xanthogranulomatous pyelonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4159984\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1313885190\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1313885199\">",
"      Thermal ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1313885206\">",
"      Active surveillance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2970\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2970|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?0/17/287\" title=\"algorithm 1\">",
"      Diagnosis and management of a small renal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2970|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/30/7650\" title=\"diagnostic image 1\">",
"      Solid small renal mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/23/42358\" title=\"diagnostic image 2\">",
"      Complex cystic small renal mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/57/35743\" title=\"diagnostic image 3\">",
"      Renal angiomyolipoma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/36/42575\" title=\"diagnostic image 4\">",
"      Xanthogranulomatous PN CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2970|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/17/26907\" title=\"table 1\">",
"      Proportion of RCCs in small renal masses",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22618?source=related_link\">",
"      Clinical features, diagnosis, and management of von Hippel-Lindau disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/32/35336?source=related_link\">",
"      Clinical manifestations, evaluation, and staging of renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/52/18250?source=related_link\">",
"      Epidemiology, pathology, and pathogenesis of renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35910?source=related_link\">",
"      Hereditary kidney cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/1/21528?source=related_link\">",
"      Overview of the treatment of renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/12/2249?source=related_link\">",
"      Presentation, diagnosis, and staging of Wilms tumor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/44/26310?source=related_link\">",
"      Radiofrequency ablation and cryoablation for renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43303?source=related_link\">",
"      Renal manifestations of tuberous sclerosis and renal angiomyolipoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27704?source=related_link\">",
"      Simple and complex renal cysts in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5546?source=related_link\">",
"      Surgical management of localized renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=related_link\">",
"      Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/26/16804?source=related_link\">",
"      Xanthogranulomatous pyelonephritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_9_2201="Major causes of musculoskeletal chest pain";
var content_f2_9_2201=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Major causes of musculoskeletal chest pain",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/9/2201/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2201/contributors\">",
"     Christopher M Wise, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/9/2201/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2201/contributors\">",
"     Don L Goldenberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2201/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/9/2201/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2201/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/9/2201/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain is one of the more common symptoms requiring medical attention in the outpatient setting. Potentially life-threatening cardiac and pulmonary problems are usually the focus of the initial diagnostic evaluation. After these areas are excluded, other conditions affecting the structures in and around the thoracic cage enter into the differential diagnosis, including diseases of the esophagus, upper abdomen, and head and neck (",
"    <a class=\"graphic graphic_table graphicRef53227 \" href=\"UTD.htm?12/43/12989\">",
"     table 1",
"    </a>",
"    ). Conditions affecting the musculoskeletal structures of the chest wall are frequently listed as potential causes of atypical or noncardiac chest pain (",
"    <a class=\"graphic graphic_table graphicRef76422 \" href=\"UTD.htm?27/58/28587\">",
"     table 2",
"    </a>",
"    ). Early recognition of these syndromes should allow more efficient and specific management of pain in patients with these conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/1-5\">",
"     1-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the major causes of musculoskeletal chest pain. The evaluation of such patients and approaches to treatment are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9335?source=see_link\">",
"     \"Clinical evaluation of musculoskeletal chest pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5592?source=see_link\">",
"     \"Treatment of musculoskeletal chest pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proportion of patients with chest pain having a musculoskeletal source varies with the clinical setting (",
"    <a class=\"graphic graphic_table graphicRef73531 \" href=\"UTD.htm?12/57/13211\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Emergency department",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the emergency department, approximately 10 to 49 percent of adults and 20 to 25 percent of children presenting with chest pain have a musculoskeletal cause [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one large retrospective study, for example, 11 percent of adults presenting with chest pain were felt to have a musculoskeletal cause. The incidence rose to 26 percent in those patients considered at low suspicion for myocardial infarction, making this the most common category of noncardiac chest pain in this setting.",
"     </li>",
"     <li>",
"      In a prospective emergency department study of 122 consecutive patients, 36 (30 percent) were felt to have chest wall tenderness due to costochondritis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/9\">",
"       9",
"      </a>",
"      ]. In 17, the tenderness reproduced their pain. Two of these patients had acute myocardial infarction (6 percent), indicating that chest wall tenderness does not exclude the presence of serious coronary disease.",
"     </li>",
"     <li>",
"      In a study of 250 patients hospitalized for chest pain, 25 of the 108 patients with atypical (noncardiac) chest pain were felt to have a musculoskeletal cause [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study of 50 patients hospitalized with chest pain without apparent cardiorespiratory cause and findings of a musculoskeletal source was able to characterize patients as having regional syndromes (50 percent), fibromyalgia (26 percent), or inflammatory joint disease (24 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among patients with a history of cocaine use, a musculoskeletal cause is commonly found. In an emergency department based study, a musculoskeletal cause was responsible for pain in 21 percent of cocaine users presenting with recurrent chest pain [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Nonemergent settings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of musculoskeletal chest pain in the nonemergent, ambulatory care setting appears to be even greater. In two reviews of episodes of chest pain evaluated in primary care practice settings, 36 and 43 percent were categorized as musculoskeletal in origin, making this the most common diagnostic category [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Musculoskeletal pain also may be present in 30 to 45 percent of patients undergoing coronary arteriography who have negative findings [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/15\">",
"     15",
"    </a>",
"    ]. Prospective studies of such patients have shown that 13 to 20 percent have chest wall tenderness that reproduces their pain, suggesting a musculoskeletal etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. Another 50 to 60 percent have chest wall tenderness that does not reproduce their pain, and is probably clinically unimportant [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Once again, however, findings suggestive of a musculoskeletal source of pain do not preclude coexisting pain due to coronary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/16,18\">",
"     16,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ISOLATED MUSCULOSKELETAL CHEST PAIN SYNDROMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of chest wall syndromes with chest pain associated with musculoskeletal inflammation or athletic injuries (",
"    <a class=\"graphic graphic_table graphicRef79217 \" href=\"UTD.htm?41/37/42587\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Common causes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Costosternal syndromes (costochondritis)",
"    </span>",
"    &nbsp;&mdash;&nbsp;A majority of patients with musculoskeletal chest wall syndromes have a more diffuse pain syndrome, in which multiple areas of tenderness are found that reproduce the described pain. The upper costal cartilages at the costochondral or costosternal junctions are most frequently involved [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/16,21-23\">",
"     16,21-23",
"    </a>",
"    ].The areas of tenderness are not accompanied by heat, erythema, or localized swelling.",
"   </p>",
"   <p>",
"    A variety of diagnostic terms have been used in this group of patients, including costochondritis, costosternal syndrome, and anterior chest wall syndrome. The diagnosis is based solely upon the ability to reproduce pain by palpation of tender areas. In some studies, certain maneuvers, such as the \"crowing rooster\" and horizontal arm flexion maneuvers, have also been found to be useful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9335?source=see_link\">",
"     \"Clinical evaluation of musculoskeletal chest pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the costosternal syndrome is a frequent diagnosis in patients with noncardiac chest pain, the causes, natural history, and treatment of this condition are poorly documented. A number of measures, including analgesics, local injections, and stretching exercises may be helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/24\">",
"     24",
"    </a>",
"    ]. Most cases follow a self-limited course with occasional exacerbations. The coexistence of fibromyalgia should be considered in patients with persistent symptoms (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Fibromyalgia'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Lower rib pain syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of names have been given to pain syndromes involving the lower ribs, including rib-tip syndrome, slipping rib, twelfth rib, and clicking rib. This condition is characterized by pain in the lower chest or upper abdomen, a tender spot on the costal margin, and reproduction of the pain by pressing on the spot [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/25\">",
"     25",
"    </a>",
"    ]. In some reports, hypermobility of the anterior end of a costal cartilage has been implicated, possibly related to indirect trauma due to lifting or twisting [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to direct palpation, another useful diagnostic test is the \"hooking maneuver\", in which the examiner's curled fingers are hooked under the ribs at the costal margin and the ribs are gently pulled forward [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Painful lower rib syndromes have been found in three to five percent of patients referred to some gastroenterology practices. A majority of patients with this condition are women, with a mean age in the mid-40s. The pain persists in 70 percent of patients followed for an average of four years from diagnosis. One-third of patients undergo further evaluations for other causes of pain, even after a definitive diagnosis is made.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Less common causes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Sternalis syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sternalis syndrome is a rarely described condition in which localized tenderness is found directly over the body of the sternum or overlying sternalis muscle, and palpation often causes radiation of pain bilaterally. This syndrome is generally self-limited, and less likely to cause persistent pain than the more diffuse costosternal syndrome. It should be differentiated from arthritis of the manubriosternal joint, which can sometimes be involved in various types of systemic arthritis. Radiographic changes may be apparent (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71428 \" href=\"UTD.htm?21/34/22062\">",
"     image 1",
"    </a>",
"    ) or increased uptake may be demonstrated by bone scanning (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54771 \" href=\"UTD.htm?42/13/43230\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Tietze's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tietze's syndrome has been defined as a benign, painful, nonsuppurative localized swelling of the costosternal, sternoclavicular, or costochondral joints, most often involving the area of the second and third ribs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/28\">",
"     28",
"    </a>",
"    ]. Only one area is usually involved, and young adults are more commonly affected. The relationship between Tietze's syndrome and the anterior chest wall involvement of the seronegative spondyloarthropathies and the more recently described sternocostoclavicular hyperostosis is uncertain, but a review has raised questions regarding the existence of Tietze's syndrome as a specific entity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tietze's syndrome is rare, and should be differentiated from more diffuse forms of myofascial chest pain (costochondritis) in which no areas of localized swelling are detected on examination. The cause of Tietze's syndrome is unknown, but antecedent upper respiratory infections and excessive coughing have been described in some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Xiphoidalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Xiphoidalgia (xiphoidynia) is another relatively rare syndrome that is characterized by localized discomfort and tenderness over the xiphoid process of the sternum [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Symptoms are often aggravated by eating a heavy meal or bending or twisting movements; they may also be associated with resumption of heavy work or a recent cough, suggesting a traumatic cause in some patients. Analgesics or local injection of an anesthetic-steroid combination are frequently curative [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Spontaneous sternoclavicular subluxation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous, atraumatic, subluxation of the sternoclavicular joint, not associated with any systemic process, has been described in small numbers of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/32\">",
"     32",
"    </a>",
"    ]. This syndrome occurs almost exclusively in women in the 40 to 60 year age group, most often in the dominant hand associated with moderate to heavy repetitive tasks. The subluxation is typically in a cranial",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anterior direction. Sclerosis of the medial clavicle is often seen radiographically. Supportive, nonoperative therapy is usually recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Posterior chest wall pain syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thoracic spinal pain syndromes are relatively common in workplace settings, with an annual prevalence ranging from 3 to 55 percent, and pain in this area may be associated with chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/33\">",
"     33",
"    </a>",
"    ]. There are several causes of posterior chest wall pain. Thoracic disc herniations are rare and difficult to diagnose, but should be considered in patients with unilateral dermatomal pain. This condition is most common in patients in their 40s, two-thirds of whom have \"band-like\" chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/34\">",
"     34",
"    </a>",
"    ]. Surgical decompression was required in only 27 percent of patients in one series, as a majority of those treated with conservative measures returned to normal activities. Pain in the upper back, associated with overhead or throwing activities of the upper extremities, may be suggestive of snapping scapula syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Costovertebral joint dysfunction is another uncommon condition causing posterior chest wall pain. Patients usually present with pain that is made worse with coughing or deep breathing, and often undergo evaluation for an intrapulmonary process, most often pulmonary embolism [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/36\">",
"     36",
"    </a>",
"    ]. On physical examination, pain is often reproduced by palpation in the area of the costovertebral junctions or directly over the affected rib, and local hyperalgesia may be caused by skin pinching. In some cases, degenerative changes are seen in the affected joints. Intercostal nerve block or facet joint injection has been used in patients who do not respond to conservative measures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18042?source=see_link&amp;anchor=H7#H7\">",
"     \"Peripheral nerve block: Techniques\", section on 'Intercostal nerve block'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The costovertebral joints may be diffusely involved in ankylosing spondylitis, but the chest pain associated with this condition is usually more diffuse, and associated with other features of the disease, including limited chest expansion on physical examination (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     RHEUMATIC DISEASES CAUSING MUSCULOSKELETAL CHEST WALL PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased sensitivity to ordinarily nonpainful stimuli in patients with fibromyalgia and involvement of thoracic joints in rheumatic diseases can be associated with musculoskeletal chest wall pain (",
"    <a class=\"graphic graphic_table graphicRef73531 \" href=\"UTD.htm?12/57/13211\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     More common causes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Fibromyalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibromyalgia is a common chronic musculoskeletal pain syndrome, characterized by diffuse musculoskeletal pain, fatigue, sleep disturbance and multiple periarticular tender points found on physical examination [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/37\">",
"     37",
"    </a>",
"    ]. The most common areas of reported pain in patients with this condition are the low back, neck, shoulders, and hips. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8056?source=see_link\">",
"     \"Clinical manifestations and diagnosis of fibromyalgia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chest pain occurs with a frequency that has ranged from eight to 71 percent. However, 85 percent of patients with fibromyalgia have tenderness over the second anterior costochondral junctions (over 60 percent characterized as moderate or greater), making this one of the most common sites of tenderness in fibromyalgia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the emergency department setting, only three percent of all patients, and eight percent of those with chest wall tenderness, appear to have fibromyalgia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/9\">",
"     9",
"    </a>",
"    ]. Similar frequencies have been reported in patients evaluated after negative coronary angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Rheumatoid arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse chest wall pain, as in costochondritis or costosternal syndrome, is not part of rheumatoid arthritis. However, there may be symptomatic involvement of the sternoclavicular joint in up to seven percent of patients with established, generalized rheumatoid arthritis, and radiographic changes may be apparent in 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Establishing the diagnosis is usually not difficult, except in the rare case in which involvement of the sternoclavicular joint is the initial manifestation of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/55/6010?source=see_link\">",
"     \"Diagnosis and differential diagnosis of rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Ankylosing spondylitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain in the thoracic spine and around the chest wall, resulting from inflammatory disease of the costovertebral, costotransverse, and thoracic apophyseal joints, is common in ankylosing spondylitis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/42\">",
"     42",
"    </a>",
"    ]. Patients with this condition usually have symptoms in the lower back or buttocks and some element of morning stiffness; however, some patients present with pain in the dorsal spine, and in one study 18 percent presented with chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/43\">",
"     43",
"    </a>",
"    ]. Involvement of these joints often results in limitation of chest expansion. This finding is frequent and typical enough to be included in commonly used criteria for the diagnosis of this disease, and is felt to be the most sensitive of the clinical elements used in these criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"     \"Clinical manifestations of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptoms in the anterior chest wall occur in five to 25 percent of patients with ankylosing spondylitis. Radiographic evidence of anterior chest involvement is more common, with 18 percent having sternoclavicular and 51 percent manubriosternal involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Psoriatic arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately five to ten percent of patients with typical psoriasis develop arthritis, which may be axial or peripheral in distribution. Some patients with psoriatic arthritis have a spondylitis similar to that seen in ankylosing spondylitis. Anterior chest wall involvement is uncommonly reported, and some confusion exists regarding the relationship of this finding to sternocostoclavicular hyperostosis. As in other disorders, anterior chest wall symptoms (1 percent) are less common than radiologic evidence of disease in the manubriosternal and sternoclavicular joint (10 to 25 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=see_link\">",
"     \"Clinical manifestations and diagnosis of psoriatic arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Less common causes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Sternocostoclavicular hyperostosis (SAPHO syndrome)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sternocostoclavicular hyperostosis is a syndrome characterized by a unique arthropathy that frequently involves the anterior chest wall and is associated with a spectrum of neutrophilic skin lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/45,47-50\">",
"     45,47-50",
"    </a>",
"    ]. Clinical descriptions of this syndrome have appeared most frequently in the Japanese and European literature under a variety of different names, including acne-associated spondyloarthropathy, chronic recurrent multifocal osteomyelitis (CRMO), and pustulotic arthrosteitis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/51\">",
"     51",
"    </a>",
"    ]. The acronym SAPHO syndrome has been proposed as a unifying term to include the various features common to these closely related disorders:",
"    <strong>",
"     s",
"    </strong>",
"    ynovitis;",
"    <strong>",
"     a",
"    </strong>",
"    cne;",
"    <strong>",
"     p",
"    </strong>",
"    ustulosis;",
"    <strong>",
"     h",
"    </strong>",
"    yperostosis; and",
"    <strong>",
"     o",
"    </strong>",
"    steomyelitis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The skin lesions associated with the SAPHO syndrome include palmoplantar pustulosis, acne conglobata, acne fulminans, hidradenitis suppurativa, and dissecting cellulitis of the scalp, all of which are characterized pathologically by neutrophilic pseudo-abscesses. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/43/30393?source=see_link\">",
"       \"Neutrophilic dermatoses\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Various patterns of asymmetric peripheral and axial arthritis have been described in association with these skin lesions, many resembling the seronegative spondyloarthropathies. However, no consistent association with HLA-B27 has been demonstrated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/51/12090?source=see_link\">",
"       \"Pathogenesis of spondyloarthritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The anterior chest wall is the most frequent area of involvement, particularly in patients with palmoplantar pustulosis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/52,53\">",
"       52,53",
"      </a>",
"      ]. Affected patients may present with pain, tenderness, and swelling of the sternum and its articulations, and some patients have restricted mobility. Enlargement and sclerosis of one or both medial clavicles may be seen radiographically, sometimes progressing to involvement of the lateral aspects. Osteolytic lesions may be visible within sclerotic areas. Similar involvement may be seen in the sternum, particularly the manubrium, and the anterior segments of the ribs. In some cases, the condition progresses to total or partial fusion and ossification involving the ribs, sternum, medial clavicles, and adjacent ligaments. Outside the chest wall, similar findings have been described in the mandible, peripheral long bones, and vertebral bodies [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients who present with bone lesions alone often develop other manifestations over time. In one study of 15 patients followed for more than a decade, 12 eventually suffered from extraosseous features, including sacroiliitis, psoriasis, and palmoplantar pustulosis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The histopathology of the bony lesions in this syndrome resembles a sterile osteomyelitis. Although the etiology of the SAPHO syndrome is unknown, occult disseminated infection or an abnormal systemic immune response to a low virulence organism, such as Propionibacterium acnes, has been implicated in some studies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/49,56-58\">",
"     49,56-58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The natural history of this condition is not well defined, but a recent report suggests that a minority of patients have a self-limited course, while a majority have either a relapsing-remitting pattern or chronic indolent pattern after an early acute phase [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of therapies have been reported to be useful in individual case reports and small case series, including nonsteroidal antiinflammatory drugs,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32983?source=see_link\">",
"     colchicine",
"    </a>",
"    , glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , and retinoids [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/59\">",
"     59",
"    </a>",
"    ]. The use of antibiotics in SAPHO syndrome has been controversial, and but a recent report suggests benefit from a 16-week course of antibiotics that is lost after antibiotics are stopped [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/60\">",
"     60",
"    </a>",
"    ]. A number of reports have shown improvement with bisphosphonate therapy, most often with intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/62/3048?source=see_link\">",
"     pamidronate",
"    </a>",
"    , including a recent report of sustained remission in 14 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. A small number of patients appear to have benefited from use of anti-tumor necrosis factor alpha therapies (intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    , subcutaneous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/24/39303?source=see_link\">",
"     adalimumab",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    ) that have been reported based on uncontrolled observations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/63-65\">",
"     63-65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Systemic lupus erythematosus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain in patients with systemic lupus erythematosus that originates in skeletal muscle or joints of the chest wall may be aggravated by breathing and therefore be described as pleuritic in quality. Finding one or more areas of tenderness helps distinguish a musculoskeletal source. Other causes of pleuritic chest pain in patients with SLE are discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=see_link&amp;anchor=H2#H2\">",
"     \"Pulmonary manifestations of systemic lupus erythematosus in adults\", section on 'Pleuritic chest pain'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Infectious arthritis of the chest wall",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection of the ribs and joints of the chest wall is uncommon. When infectious arthritis does occur, it usually affects the sternoclavicular joint. Reviews have noted patients with sternoclavicular infections, a history of intravenous drug abuse, a distant site of infection, diabetes, and rheumatoid arthritis to be the most commonly associated conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. The most common causative organism was Pseudomonas aeruginosa in patients with a history of drug abuse, while Staphylococcus aureus and various streptococcal species predominated in those without such a history. The risk of developing an abscess in the surrounding area was about 20 to 25 percent, and such spread has been associated with mediastinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Relapsing polychondritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;This rare condition, characterized by inflammatory lesions of cartilage, classically presents with inflammation of the ears, nasal cartilage, and respiratory tract. Associated problems in some patients include a nonerosive synovitis, ocular inflammation, and inner ear dysfunction. Inflammation of the costochondral and manubriosternal areas may occur in up to one-quarter of patients, with rare reports of destructive lesions resulting in flail chest [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/69\">",
"     69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/63/26616?source=see_link\">",
"     \"Clinical manifestations of relapsing polychondritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     NONRHEUMATIC SYSTEMIC CAUSES OF CHEST WALL PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several systemic disorders are characterized by bony involvement that can lead to chest wall pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Stress or insufficiency fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress fractures occur as a result of repeated loading of otherwise healthy, well mineralized bone. Vigorous repetitive athletic activities such as rowing or throwing may cause stress fractures of bones of the chest wall [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23866?source=see_link\">",
"     \"Overview of stress fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An insufficiency fracture occurs when the mechanical strength of a bone is reduced to the point that a stress, which would not fracture a healthy bone, breaks the weak one. Insufficiency fractures of the ribs should be considered in patients with chest pain and risk factors for osteoporosis or osteomalacia, including rheumatoid arthritis treated chronically with glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/70\">",
"     70",
"    </a>",
"    ], chronic kidney disease, and vitamin D deficiency, especially in the elderly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/25/15767?source=see_link&amp;anchor=H12#H12\">",
"     \"Causes of hypophosphatemia\", section on 'Vitamin D deficiency or resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Neoplasms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary or secondary neoplasms infrequently involve the chest wall, usually as mass lesions. Lung or breast carcinoma, for example, may involve the chest wall by direct extension or metastases, while other neoplasms occasionally cause hematogenous metastases. Primary neoplasms of the chest wall are rare, and include various sarcomas, malignant fibrous histiocytoma, and multiple myeloma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Sickle cell disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acute chest syndrome described as a part of sickle cell crisis has usually been attributed to pulmonary infarction. However, one report, using technetium bone scans, found that rib infarctions may contribute in many cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/72\">",
"     72",
"    </a>",
"    ]. There may also be an association of rib involvement with the abdominal pain and distension that is part of some crises [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2201/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/27/34225?source=see_link\">",
"       \"Patient information: Costochondritis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders that have musculoskeletal chest pain as a clinical feature may be divided into those due to isolated (nonsystemic) inflammation or injury, those due to rheumatic diseases , and those with nonrheumatic systemic causes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Musculoskeletal problems are a common cause of chest pain in both adults (10 to 15 percent) and children (20 to 25 percent) presenting to emergency departments, and probably an even greater proportion of those seen in nonemergent settings. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Prevalence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of chest wall tenderness, the hallmark of chest pain of musculoskeletal origin, does not preclude the presence of a more serious, potentially life-threatening disorder such as ischemic heart disease or pulmonary embolism. Coexistence of chest wall tenderness and myocardial infarction has been noted in small minority of patients presenting to an emergency department with chest pain. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Emergency department'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common isolated musculoskeletal disorders causing chest pain include: costosternal (costochondral) syndromes and lower rib syndromes. Less common or rare causes include Sternalis syndrome, Tietze's syndrome, xiphoidalgia, spontaneous sternoclavicular subluxation, and various posterior chest wall syndromes. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Isolated musculoskeletal chest pain syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fibromyalgia is the most prevalent of the rheumatic disorders that cause musculoskeletal chest pain. Inflammation of joints of the chest wall may occur in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Less common or rare rheumatic disorders causing musculoskeletal chest pain include the SAPHO syndrome (with",
"      <strong>",
"       s",
"      </strong>",
"      ynovitis,",
"      <strong>",
"       a",
"      </strong>",
"      cne,",
"      <strong>",
"       p",
"      </strong>",
"      ustulosis,",
"      <strong>",
"       h",
"      </strong>",
"      yperostosis, and sterile",
"      <strong>",
"       o",
"      </strong>",
"      steomyelitis), systemic lupus erythematosus, septic (infectious) arthritis, and relapsing polychondritis. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Rheumatic diseases causing musculoskeletal chest wall pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nonrheumatic disorders that are systemic and can cause musculoskeletal chest pain include insufficiency fractures of fragile bones in osteoporosis or osteomalacia, pathologic fractures or bone pain due to malignant disease, and rib infarction due to sickle cell disease. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Nonrheumatic systemic causes of chest wall pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Stress fractures result when healthy bones are subjected to repeated loading. Athletes involved in strenuous upper body exercise are at risk (eg, rowing, throwing). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23866?source=see_link\">",
"       \"Overview of stress fractures\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/1\">",
"      Habib PA, Huang GS, Mendiola JA, Yu JS. Anterior chest pain: musculoskeletal considerations. Emerg Radiol 2004; 11:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/2\">",
"      Freeston J, Karim Z, Lindsay K, Gough A. Can early diagnosis and management of costochondritis reduce acute chest pain admissions? J Rheumatol 2004; 31:2269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/3\">",
"      Eslick GD. Classification, natural history, epidemiology, and risk factors of noncardiac chest pain. Dis Mon 2008; 54:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/4\">",
"      Stochkendahl MJ, Christensen HW. Chest pain in focal musculoskeletal disorders. Med Clin North Am 2010; 94:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/5\">",
"      Yelland M, Cayley WE Jr, Vach W. An algorithm for the diagnosis and management of chest pain in primary care. Med Clin North Am 2010; 94:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/6\">",
"      Cilia C, Malatino LS, Puccia G, et al. The prevalence of the cardiac origin of chest pain: the experience of a rural area of southeast Italy. Intern Emerg Med 2010; 5:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/7\">",
"      Thull-Freedman J. Evaluation of chest pain in the pediatric patient. Med Clin North Am 2010; 94:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/8\">",
"      Son MB, Sundel RP. Musculoskeletal causes of pediatric chest pain. Pediatr Clin North Am 2010; 57:1385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/9\">",
"      Disla E, Rhim HR, Reddy A, et al. Costochondritis. A prospective analysis in an emergency department setting. Arch Intern Med 1994; 154:2466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/10\">",
"      Spalding L, Reay E, Kelly C. Cause and outcome of atypical chest pain in patients admitted to hospital. J R Soc Med 2003; 96:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/11\">",
"      How J, Volz G, Doe S, et al. The causes of musculoskeletal chest pain in patients admitted to hospital with suspected myocardial infarction. Eur J Intern Med 2005; 16:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/12\">",
"      Cunningham R, Walton MA, Weber JE, et al. One-year medical outcomes and emergency department recidivism after emergency department observation for cocaine-associated chest pain. Ann Emerg Med 2009; 53:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/13\">",
"      Klinkman MS, Stevens D, Gorenflo DW. Episodes of care for chest pain: a preliminary report from MIRNET. Michigan Research Network. J Fam Pract 1994; 38:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/14\">",
"      Verdon F, Herzig L, Burnand B, et al. Chest pain in daily practice: occurrence, causes and management. Swiss Med Wkly 2008; 138:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/15\">",
"      Brunse MH, Stochkendahl MJ, Vach W, et al. Examination of musculoskeletal chest pain - an inter-observer reliability study. Man Ther 2010; 15:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/16\">",
"      Wolf E, Stern S. Costosternal syndrome: its frequency and importance in differential diagnosis of coronary heart disease. Arch Intern Med 1976; 136:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/17\">",
"      Bechgaard P. Segmental thoracic pain in patients admitted to a medical department and a coronary unit. Acta Med Scand Suppl 1981; 644:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/18\">",
"      Levine PR, Mascette AM. Musculoskeletal chest pain in patients with \"angina\": a prospective study. South Med J 1989; 82:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/19\">",
"      Wise CM, Semble EL, Dalton CB. Musculoskeletal chest wall syndromes in patients with noncardiac chest pain: a study of 100 patients. Arch Phys Med Rehabil 1992; 73:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/20\">",
"      Gregory PL, Biswas AC, Batt ME. Musculoskeletal problems of the chest wall in athletes. Sports Med 2002; 32:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/21\">",
"      Fam AG, Smythe HA. Musculoskeletal chest wall pain. CMAJ 1985; 133:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/22\">",
"      Calabro JJ. Costochondritis. N Engl J Med 1977; 296:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/23\">",
"      Epstein SE, Gerber LH, Borer JS. Chest wall syndrome. A common cause of unexplained cardiac pain. JAMA 1979; 241:2793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/24\">",
"      Rovetta G, Sessarego P, Monteforte P. Stretching exercises for costochondritis pain. G Ital Med Lav Ergon 2009; 31:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/25\">",
"      Scott EM, Scott BB. Painful rib syndrome--a review of 76 cases. Gut 1993; 34:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/26\">",
"      Davies-Colley R. SLIPPING RIB. Br Med J 1922; 1:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/27\">",
"      Heinz GJ, Zavala DC. Slipping rib syndrome. JAMA 1977; 237:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/28\">",
"      Tietze, A. Uber eine eigneartige Haufund von Fallen mit Dystrophie der Rippenknorpel. Berlin Klin Wschr 1921; 58:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/29\">",
"      Aeschlimann A, Kahn MF. Tietze's syndrome: a critical review. Clin Exp Rheumatol 1990; 8:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/30\">",
"      LIPKIN M, FULTON LA, WOLFSON EA. The syndrome of the hypersensitive xiphoid. N Engl J Med 1955; 253:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/31\">",
"      Howell JM. Xiphodynia: a report of three cases. J Emerg Med 1992; 10:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/32\">",
"      van Holsbeeck M, van Melkebeke J, Dequeker J, Pennes DR. Radiographic findings of spontaneous subluxation of the sternoclavicular joint. Clin Rheumatol 1992; 11:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/33\">",
"      Briggs AM, Bragge P, Smith AJ, et al. Prevalence and associated factors for thoracic spine pain in the adult working population: a literature review. J Occup Health 2009; 51:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/34\">",
"      Brown CW, Deffer PA Jr, Akmakjian J, et al. The natural history of thoracic disc herniation. Spine (Phila Pa 1976) 1992; 17:S97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/35\">",
"      Kuhne M, Boniquit N, Ghodadra N, et al. The snapping scapula: diagnosis and treatment. Arthroscopy 2009; 25:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/36\">",
"      Arroyo JF, Jolliet P, Junod AF. Costovertebral joint dysfunction: another misdiagnosed cause of atypical chest pain. Postgrad Med J 1992; 68:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/37\">",
"      Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/38\">",
"      Almansa C, Wang B, Achem SR. Noncardiac chest pain and fibromyalgia. Med Clin North Am 2010; 94:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/39\">",
"      DILSEN N, McEWEN C, POPPEL M, et al. A comparative roentgenologic study of rheumatoid arthritis and rheumatoid (ankylosing) spondylitis. Arthritis Rheum 1962; 5:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/40\">",
"      Kalliom&auml;ki JL, Viitanen SM, Virtama P. Radiological findings of sternoclavicular joints in rheumatoid arthritis. Acta Rheumatol Scand 1968; 14:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/41\">",
"      Dura PA, Daniel TM, Frierson HF Jr, Brunner CM. Chest wall mass in rheumatoid arthritis. J Rheumatol 1993; 20:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/42\">",
"      GOOD AE. The chest pain of ankylosing spondylitis. Its place in the differential diagnosis of heart pain. Ann Intern Med 1963; 58:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/43\">",
"      Dawes PT, Sheeran TP, Hothersall TE. Chest pain--a common feature of ankylosing spondylitis. Postgrad Med J 1988; 64:27.",
"     </a>",
"    </li>",
"    <li>",
"     Calin, A. Spondyloarthropathies. Grune and Stratton, Orlando, 1984.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/45\">",
"      Jurik AG. Seronegative anterior chest wall syndromes. A study of the findings and course at radiography. Acta Radiol Suppl 1992; 381:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/46\">",
"      Guglielmi G, Cascavilla A, Scalzo G, et al. Imaging of sternocostoclavicular joint in spondyloarthropaties and other rheumatic conditions. Clin Exp Rheumatol 2009; 27:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/47\">",
"      Saghafi M, Henderson MJ, Buchanan WW. Sternocostoclavicular hyperostosis. Semin Arthritis Rheum 1993; 22:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/48\">",
"      Kahn MF, Chamot AM. SAPHO syndrome. Rheum Dis Clin North Am 1992; 18:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/49\">",
"      Magrey M, Khan MA. New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. Curr Rheumatol Rep 2009; 11:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/50\">",
"      Colina M, Govoni M, Orzincolo C, Trotta F. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 2009; 61:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/51\">",
"      Tlougan BE, Podjasek JO, O'Haver J, et al. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature. Pediatr Dermatol 2009; 26:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/52\">",
"      Jurik AG. Anterior chest wall involvement in patients with pustulosis palmoplantaris. Skeletal Radiol 1990; 19:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/53\">",
"      Earwaker JW, Cotten A. SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol 2003; 32:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/54\">",
"      Sall&eacute;s M, Oliv&eacute; A, Perez-Andres R, et al. The SAPHO syndrome: a clinical and imaging study. Clin Rheumatol 2011; 30:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/55\">",
"      Vittecoq O, Said LA, Michot C, et al. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum 2000; 43:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/56\">",
"      Kotilainen P, Merilahti-Palo R, Lehtonen OP, et al. Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. J Rheumatol 1996; 23:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/57\">",
"      Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P, et al. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 2008; 47:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/58\">",
"      Govoni M, Colina M, Massara A, Trotta F. \"SAPHO syndrome and infections\". Autoimmun Rev 2009; 8:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/59\">",
"      Olivieri I, Padula A, Palazzi C. Pharmacological management of SAPHO syndrome. Expert Opin Investig Drugs 2006; 15:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/60\">",
"      Assmann G, Kueck O, Kirchhoff T, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther 2009; 11:R140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/61\">",
"      Kerrison C, Davidson JE, Cleary AG, Beresford MW. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford) 2004; 43:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/62\">",
"      Colina M, La Corte R, Trotta F. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol 2009; 27:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/63\">",
"      Olivieri I, Padula A, Ciancio G, et al. Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis 2002; 61:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/64\">",
"      Wagner AD, Andresen J, Jendro MC, et al. Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 2002; 46:1965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/65\">",
"      Ben Abdelghani K, Dran DG, Gottenberg JE, et al. Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol 2010; 37:1699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/66\">",
"      Wohlgethan JR, Newberg AH, Reed JI. The risk of abscess from sternoclavicular septic arthritis. J Rheumatol 1988; 15:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/67\">",
"      Ross JJ, Shamsuddin H. Sternoclavicular septic arthritis: review of 180 cases. Medicine (Baltimore) 2004; 83:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/68\">",
"      Pollack MS. Staphylococcal mediastinitis due to sternoclavicular pyarthrosis: CT appearance. J Comput Assist Tomogr 1990; 14:924.",
"     </a>",
"    </li>",
"    <li>",
"     Piette, JC, Vinceneux, P. Relapsing polychondritis, In: Kelley's Textbook of Rheumatology, 7th ed, Harris, ED, Budd, RC, Genovese, MC, et al. (Eds), Saunders, Elsevier Saunders, 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/70\">",
"      Fam AG, Shuckett R, McGillivray DC, Little AH. Stress fractures in rheumatoid arthritis. J Rheumatol 1983; 10:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/71\">",
"      Fortier M, Mayo JR, Swensen SJ, et al. MR imaging of chest wall lesions. Radiographics 1994; 14:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/72\">",
"      Rucknagel DL, Kalinyak KA, Gelfand MJ. Rib infarcts and acute chest syndrome in sickle cell diseases. Lancet 1991; 337:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2201/abstract/73\">",
"      Serjeant GR, Ceulaer CD, Lethbridge R, et al. The painful crisis of homozygous sickle cell disease: clinical features. Br J Haematol 1994; 87:586.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5622 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-88.81.100.162-2094B74F85-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2201=[""].join("\n");
var outline_f2_9_2201=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Emergency department",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Nonemergent settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ISOLATED MUSCULOSKELETAL CHEST PAIN SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Common causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Costosternal syndromes (costochondritis)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Lower rib pain syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Less common causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Sternalis syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Tietze's syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Xiphoidalgia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Spontaneous sternoclavicular subluxation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Posterior chest wall pain syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      RHEUMATIC DISEASES CAUSING MUSCULOSKELETAL CHEST WALL PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      More common causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Fibromyalgia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Ankylosing spondylitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Psoriatic arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Less common causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Sternocostoclavicular hyperostosis (SAPHO syndrome)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Infectious arthritis of the chest wall",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Relapsing polychondritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      NONRHEUMATIC SYSTEMIC CAUSES OF CHEST WALL PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Stress or insufficiency fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Neoplasms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/5622\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5622|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/34/22062\" title=\"diagnostic image 1\">",
"      Manubriosternal osteoarthrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/13/43230\" title=\"diagnostic image 2\">",
"      Anterior chest pain bone scan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5622|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/43/12989\" title=\"table 1\">",
"      Other diagnoses chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/58/28587\" title=\"table 2\">",
"      Etiology of chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/57/13211\" title=\"table 3\">",
"      Systemic causes MS chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/37/42587\" title=\"table 4\">",
"      Isolated chest pain syndromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/25/15767?source=related_link\">",
"      Causes of hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/7/9335?source=related_link\">",
"      Clinical evaluation of musculoskeletal chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8056?source=related_link\">",
"      Clinical manifestations and diagnosis of fibromyalgia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=related_link\">",
"      Clinical manifestations and diagnosis of psoriatic arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=related_link\">",
"      Clinical manifestations of ankylosing spondylitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/63/26616?source=related_link\">",
"      Clinical manifestations of relapsing polychondritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/55/6010?source=related_link\">",
"      Diagnosis and differential diagnosis of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/43/30393?source=related_link\">",
"      Neutrophilic dermatoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23866?source=related_link\">",
"      Overview of stress fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/51/12090?source=related_link\">",
"      Pathogenesis of spondyloarthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/27/34225?source=related_link\">",
"      Patient information: Costochondritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18042?source=related_link\">",
"      Peripheral nerve block: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=related_link\">",
"      Pulmonary manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5592?source=related_link\">",
"      Treatment of musculoskeletal chest pain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_9_2202="Clinical features of congenital long QT syndrome";
var content_f2_9_2202=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features of congenital long QT syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/9/2202/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2202/contributors\">",
"     Stephen P Seslar, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2202/contributors\">",
"     Peter J Zimetbaum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2202/contributors\">",
"     Charles I Berul, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2202/contributors\">",
"     Mark E Josephson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/9/2202/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2202/contributors\">",
"     John K Triedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2202/contributors\">",
"     Samuel L&eacute;vy, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2202/contributors\">",
"     Samuel Asirvatham, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/9/2202/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/9/2202/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/9/2202/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long QT syndrome (LQTS) is a disorder of myocardial repolarization characterized by a prolonged QT interval on the electrocardiogram (ECG) (",
"    <a class=\"graphic graphic_waveform graphicRef77018 \" href=\"UTD.htm?26/24/27008\">",
"     waveform 1",
"    </a>",
"    ) and an increased risk of sudden cardiac death [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. This syndrome is associated with an increased risk of a characteristic life-threatening cardiac arrhythmia, known as torsades de pointes or \"twisting of the points\" (",
"    <a class=\"graphic graphic_waveform graphicRef53891 graphicRef73827 \" href=\"UTD.htm?3/40/3719\">",
"     waveform 2A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The primary symptoms in patients with LQTS include palpitations, syncope, seizures, and cardiac arrest.",
"   </p>",
"   <p>",
"    The long QT syndrome may be congenital or acquired [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. Mutations in seven genes have been identified thus far in patients with genetic LQTS; the distinct genetic types are designated LQT 1 through 12 (",
"    <a class=\"graphic graphic_table graphicRef58937 \" href=\"UTD.htm?42/34/43565\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link\">",
"     \"Genetics of congenital and acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Two clinical phenotypes have been described in congenital LQTS that differ in the type of inheritance and the presence or absence of sensorineural hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The more common autosomal dominant form, the Romano-Ward syndrome, has a purely cardiac phenotype.",
"     </li>",
"     <li>",
"      The autosomal recessive form, the Jervell and Lange-Nielsen syndrome, is associated with LQTS and sensorineural deafness, and a more malignant clinical course [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Congenital sensorineural deafness'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Romano-Ward syndrome can result from any of the mutations found thus far in congenital LQTS or other as yet unidentified mutations; in comparison, the Jervell and Lange-Nielsen syndrome thus far has only been described in LQT1 and LQT5, both of which affect the slowly acting component of the outward-rectifying potassium current (IKs) (",
"    <a class=\"graphic graphic_table graphicRef58937 \" href=\"UTD.htm?42/34/43565\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link&amp;anchor=H2#H2\">",
"     \"Genetics of congenital and acquired long QT syndrome\", section on 'Phenotypes of congenital LQTS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acquired LQTS usually results from drug therapy or electrolyte disturbances (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/11\">",
"     11",
"    </a>",
"    ]. In some patients with acquired LQTS, an underlying genetic predisposition has been identified. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Acquired LQTS'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The epidemiology, clinical features, and conditions that are associated with congenital LQTS will be reviewed here. The diagnosis and management of congenital LQTS in children and adults and the clinical features of acquired LQTS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=see_link\">",
"     \"Diagnosis of congenital long QT syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26682?source=see_link\">",
"     \"Prognosis and management of congenital long QT syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital LQTS is thought to account for 3000 to 4000 annual sudden deaths in childhood in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/12\">",
"     12",
"    </a>",
"    ]. Although it is difficult to determine accurately, the incidence of congenital LQTS has been estimated to be between 1 in 2500 to 10,000 in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/12-14\">",
"     12-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency of LQTS mutations may be much greater than these figures indicate since some mutations result in only subtle clinical abnormalities and do not come to medical attention. The magnitude of this effect was illustrated in a study of 817 family members with documented congenital LQTS by genetic testing [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/15\">",
"     15",
"    </a>",
"    ]. Defining LQTS as a QTc &gt;440 msec in men and 460 msec in women, the average QTc penetrance was 60 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link\">",
"     \"Genetics of congenital and acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, one of the phenotypes of congenital LQTS, the Jervell and Lange-Nielsen syndrome, is associated with congenital neuronal deafness. The estimated frequency with which LQTS occurs in children with congenital deafness ranges from 0.3 to 3.7 percent. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Congenital sensorineural deafness'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features of LQTS have been established by the examination of large series of patients with genetic LQTS, the largest of which is the International Long-QT Syndrome Registry. This registry also has been a major source of data that led to the identification of specific genes involved in LQTS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link\">",
"     \"Genetics of congenital and acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with LQTS may be asymptomatic. Such patients typically come to medical attention because they have an affected family member or a prolonged QT interval corrected for heart rate (QTc) is identified on an ECG obtained for some other reason. Symptomatic patients can present with palpitations, presyncope, syncope, seizures, or cardiac arrest. Syncopal episodes may be misdiagnosed as a primary seizure disorder, with potentially fatal consequences. (See",
"    <a class=\"local\" href=\"#H34850992\">",
"     'Seizures'",
"    </a>",
"    below.) Neuronal deafness is an associated feature in patients with the Jervell and Lange-Nielsen syndrome. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Congenital sensorineural deafness'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    It has been thought that most individuals with congenital LQTS have QT prolongation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    clinical symptoms. However, some mutations have low penetrance. This was illustrated in a report of nine families with apparently sporadic LQTS in which no member other than the proband had clinical signs of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/16\">",
"     16",
"    </a>",
"    ]. Penetrance was only 25 percent, and conventional clinical diagnostic criteria identified only 38 percent of gene carriers. Silent gene carriers and their affected offspring would be at risk for unexpected torsades de pointes (TdP), especially if exposed to drugs or other factors that can prolong the QT interval (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Acquired LQTS'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pediatric Electrophysiology Society study &ndash; The presenting clinical features of LQTS were described in a series of 287 patients younger than 21 years of age from the registry of the Pediatric Electrophysiology Society [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/17\">",
"       17",
"      </a>",
"      ]. Patients included in this registry had either a prolonged QTc (&gt;0.44 sec)",
"      <strong>",
"       or",
"      </strong>",
"      both a family history of LQTS and one of the following: unexplained syncope, seizures, or cardiac arrest preceded by exercise or emotion. The following findings were noted:",
"     </li>",
"     <li>",
"      The mean age at presentation was 6.8 years; 20 percent presented at less than one month of age, and 36 percent presented between the ages of nine and 15 years. The age ranged from in utero to 21 years. Males and females were equally affected.",
"     </li>",
"     <li>",
"      175 patients (61 percent) were symptomatic at presentation. The presenting symptoms were syncope, seizures, and cardiac arrest in 26, 10, and 9 percent of patients, respectively. Other symptoms included presyncope and palpitations.",
"     </li>",
"     <li>",
"      Among symptomatic patients, symptoms were related to exercise in 67 percent, to exercise and emotion in 18 percent, to emotion alone in 7 percent, to loud noise and exercise in 3 percent, and to anesthesia in 2 percent. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Triggers of arrhythmia'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Family history was positive for LQTS in 39 percent and for sudden cardiac death (SCD) in 31 percent.",
"     </li>",
"     <li>",
"      Hearing loss was present in 4.5 percent. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Congenital sensorineural deafness'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      International Long-QT Syndrome Registry &ndash; The largest database of patients with LQTS is the International Long-QT Syndrome Registry. The clinical features of LQTS have been described in 3343 individuals from 328 families with one or more affected members enrolled in this registry [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/18\">",
"       18",
"      </a>",
"      ]. The proband (or index case) was considered the first affected family member who was identified independently of relatives.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The probands were diagnosed at an average age of 21 years, and were thus older on average than the patients studied by the Pediatric Electrophysiology Society. In contrast to the patients in the Pediatric Electrophysiology Society cohort, the majority of probands in this database (69 percent) were female. A number of findings in the probands occurred more often than in other affected or unaffected family members. These included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pre-enrollment syncope or cardiac arrest with resuscitation &ndash; 80 percent",
"     </li>",
"     <li>",
"      QTc &ge;0.50 sec &ndash; 52 percent",
"     </li>",
"     <li>",
"      History of ventricular tachyarrhythmia &ndash; 47 percent",
"     </li>",
"     <li>",
"      Resting heart rate &lt;60",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      &ndash; 31 percent",
"     </li>",
"     <li>",
"      Congenital deafness &ndash; 7 percent (see",
"      <a class=\"local\" href=\"#H21\">",
"       'Congenital sensorineural deafness'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34850992\">",
"    <span class=\"h3\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syncopal episodes associated with ventricular arrhythmias due to LQTS may have tonic-clonic movements and may be misdiagnosed as a primary seizure disorder, often with tragic consequences [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. Distinguishing between these entities may be challenging, and they may overlap. In addition, the resting ECG may not establish the diagnosis.",
"   </p>",
"   <p>",
"    These problems were illustrated in a report of eight patients treated for a seizure disorder for up to five years until arrhythmia was identified as the underlying cause [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Of the five patients who had LQTS, QT prolongation on baseline ECG was significant in only one and borderline in two.",
"     </li>",
"     <li>",
"      The diagnosis was established in four by the appearance of exercise-induced TdP type polymorphic VT with Holter monitoring. One patient died while being treated for seizures, and a diagnosis of LQTS was made retrospectively by examination of family members.",
"     </li>",
"     <li>",
"      Minor abnormalities detected on electroencephalography may have contributed to the delay of the diagnosis of arrhythmia in four patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Emotional stress or physical exertion preceding syncope or seizure may suggest the possibility of LQTS-associated arrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/20,22\">",
"     20,22",
"    </a>",
"    ]. Timing of the loss of consciousness associated with a seizure also has been proposed as a risk factor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/21\">",
"     21",
"    </a>",
"    ]. However, in a larger series, eight of 126 patients who had loss of consciousness before convulsions did not have LQTS, and loss of consciousness did not precede convulsions in two with LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A screening ECG should be performed in all patients following a first afebrile seizure or unexplained syncope, including episodes consistent with neurocardiogenic (vasovagal) syncope. Those with borderline or prolonged QT intervals should be referred to a cardiologist for further evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Types of arrhythmia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The range of arrhythmias that can occur in LQTS was illustrated in the above report from the Pediatric Electrophysiology Society of 287 children, 61 percent of whom were symptomatic at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/17\">",
"     17",
"    </a>",
"    ]. In this symptomatic population, the initial routine ECG revealed ventricular arrhythmias in 16 percent:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Torsades de pointes &ndash; 6 percent at rest (and 9 percent during an exercise test)",
"     </li>",
"     <li>",
"      Multiform ventricular premature beats &ndash; 5 percent",
"     </li>",
"     <li>",
"      Uniform ventricular premature beats &ndash; 4 percent",
"     </li>",
"     <li>",
"      Monomorphic VT &ndash; 1 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, bradycardia was present in 20 percent and atrioventricular block in 5 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Torsades de pointes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The stereotypic arrhythmia associated with LQTS is a form of polymorphic ventricular tachycardia called torsades de pointes. Polymorphic VT is defined as a ventricular rhythm faster than 100 beats per min with frequent variations of the QRS axis, morphology, or both [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. In the specific case of TdP, these variations take the form of a progressive, sinusoidal, cyclic alteration of the QRS axis (",
"    <a class=\"graphic graphic_waveform graphicRef53891 graphicRef73827 \" href=\"UTD.htm?3/40/3719\">",
"     waveform 2A-B",
"    </a>",
"    ). The peaks of the QRS complexes appear to \"twist\" around the isoelectric line of the recording, hence the name \"torsades de pointes\" (TdP) or \"twisting of the points.\"",
"   </p>",
"   <p>",
"    Typical features of TdP include a markedly prolonged QT interval in the last sinus beat preceding the onset of the arrhythmia, a ventricular rate of 160 to 250 beats per minute, irregular RR intervals, and a cycling of the QRS axis through 180 degrees every five to 20 beats [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Torsades de pointes episodes usually are short-lived and terminate spontaneously. However, patients may experience multiple episodes of the arrhythmia and episodes can recur in rapid succession and may induce syncope or progress to ventricular fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Among probands from the International Registry, 80 percent presented with syncope or resuscitated cardiac arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Bradycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bradycardia (defined as a resting heart rate less than 60",
"    <span class=\"nowrap\">",
"     beats/min)",
"    </span>",
"    is a common finding in patients with LQTS, occurring in 20 percent of patients in the Pediatric Electrophysiology Society study and in 31 percent of probands in a study from the International Registry [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Bradycardia appears to be more common in children during the first three years of life [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bradycardia has also been reported in fetuses and neonates with LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. Among of 42 LQTS subjects identified by family history of LQTS or referral for fetal arrhythmia in whom recordings of fetal heart rate were performed, the presence of a fetal heart rate of 110 beats per minute or less (15 percent of patients), or a fetal heart rate of the third percentile or lower for gestational age (66 percent of patients), predicted the presence of LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/27\">",
"     27",
"    </a>",
"    ]. Patients with fetal bradycardia meeting the above parameters may be candidates for more aggressive evaluation for LQTS in the neonatal period. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=see_link\">",
"     \"Diagnosis of congenital long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bradyarrhythmias are more frequently associated with LQT3, which is caused by mutations in the cardiac sodium channel gene (SCN5A) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/28\">",
"     28",
"    </a>",
"    ]. Because the cardiac sodium channel is responsible for phase 0 (rapid depolarization) of the cardiac action potential, it is likely that abnormalities of sodium conductance are responsible for the sinus node dysfunction seen in these patients. Bradyarrhythmias have also been reported in neonates with LQT1 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38422?source=see_link\">",
"     \"Myocardial action potential and action of antiarrhythmic drugs\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     AV block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrioventricular (AV) block was noted in fifteen patients (5 percent) in the Pediatric Electrophysiology Society study [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/17\">",
"     17",
"    </a>",
"    ]. Thirteen had second degree AV block and two had complete AV block. Second degree AV block was also reported in a series of 15 neonates, eight of whom had LQT2 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/26\">",
"     26",
"    </a>",
"    ]. In this series, three infants died during the first month of life, two with sudden death and one with sepsis.",
"   </p>",
"   <p>",
"    One mechanism of 2:1 AV block is prolonged ventricular refractoriness, which inhibits alternate depolarizations. True AV conduction abnormalities account for the remaining cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Triggers of arrhythmia",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34850781\">",
"    <span class=\"h3\">",
"     External triggers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The onset of ventricular arrhythmia, most often TdP, in patients with LQTS often is initiated by an external trigger [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/17,18,29-31\">",
"     17,18,29-31",
"    </a>",
"    ]. Triggers can include exercise, noise, emotion, sudden wakening from sleep by an alarm clock, telephone, thunder, swimming or diving. Among symptomatic patients in the Pediatric Electrophysiology Society study, symptoms were related to exercise in 67 percent, to exercise and emotion in 18 percent, to emotion alone in 7 percent, to loud noise and exercise in 3 percent, and to anesthesia in 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Pause dependence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of repolarization, which defines the duration of the T wave and the QT interval, varies in relation to the preceding RR interval. At higher heart rates, with shorter RR intervals, repolarization accelerates and the QT interval shortens. The opposite occurs during slower heart rates with longer RR intervals.",
"   </p>",
"   <p>",
"    Pause dependence refers to the phenomenon in which TdP is initiated by a \"long-short\" or \"short-long-short\" sequence (",
"    <a class=\"graphic graphic_waveform graphicRef73827 \" href=\"UTD.htm?42/7/43134\">",
"     waveform 2B",
"    </a>",
"    ). This beat-to-beat variation is caused by ectopic beats. Following an ectopic beat, there is a slight pause, in which the RR interval lengthens for one beat (the \"long\" RR in the sequence). This pause causes the following QT interval to prolong. If, during this lengthened QT interval, a second ectopic beat occurs early (a \"short\" RR interval), during the vulnerable period of repolarization, TdP can develop.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Influence of genotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;The great majority of cases of LQTS are accounted for by three of the seven genotypes: LQT1 (40 to 55 percent), LQT2 (35 to 45 percent), and LQT3 (8 to 10 percent) (",
"    <a class=\"graphic graphic_table graphicRef58937 \" href=\"UTD.htm?42/34/43565\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/29,32\">",
"     29,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link\">",
"     \"Genetics of congenital and acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is an association between the triggers that initiate arrhythmic events and the specific genotype of LQTS (",
"    <a class=\"graphic graphic_figure graphicRef64239 \" href=\"UTD.htm?9/27/9662\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/7,29\">",
"     7,29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Arrhythmic events in patients with LQT1 are most often related to exercise which, in a review that included 371 patients with LQT1, accounted for 62 percent of events [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/29\">",
"       29",
"      </a>",
"      ]. The sensitivity of patients with LQT1 to exercise may be related to exaggerated prolongation of the QT interval during exercise [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/33\">",
"       33",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link&amp;anchor=H18#H18\">",
"       \"Genetics of congenital and acquired long QT syndrome\", section on 'Variability of clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Events related to swimming (occurring either immediately after diving into water or during recreational or competitive swimming activities) may be specific for LQT1 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/31,34,35\">",
"       31,34,35",
"      </a>",
"      ]. However, swimming-related events may also occur with other disorders such as familial polymorphic ventricular tachycardia [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/36\">",
"       36",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37641?source=see_link&amp;anchor=H3#H3\">",
"       \"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval\", section on 'Catecholaminergic polymorphic VT'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute arousal events (such as exercise, emotion, or noise) are much more likely triggers in LQT1 and LQT2 than LQT3 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/29,37\">",
"       29,37",
"      </a>",
"      ]. In one report, for example the relative frequencies were 85, 67, and 33 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/37\">",
"       37",
"      </a>",
"      ]. Events triggered by auditory stimuli, such as an alarm clock or telephone ringing, are most typically seen in LQT2 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/30,31\">",
"       30,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pause-dependent TdP is common among patients with LQT2, but rare in patients with LQT1 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/38\">",
"       38",
"      </a>",
"      ]. In a series of 50 patients with congenital LQTS who had the onset of TdP captured on an ECG, a pause preceded the onset of TdP in 68 percent of patients with LQT2, compared to none of the patients with LQT1. Other genotypes were not adequately represented in this series to assess the frequency of pause-dependent TdP. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Pause dependence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with LQT3 are at highest risk of events when at rest or asleep, while the risk is low in LQTS, accounting for only 3 percent of events in LQT1 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Acquired LQTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of acquired LQTS, such as drugs, hypokalemia, and hypomagnesemia (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 2",
"    </a>",
"    ) also can precipitate ventricular arrhythmia in patients with congenital LQTS. As noted above, mutations in some families have low penetrance, and arrhythmic events may only occur after such an added trigger, the so-called \"second hit\" hypothesis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/16\">",
"     16",
"    </a>",
"    ]. There are also an increasing number of reports of \"forme fruste\" mutations or polymorphisms in LQTS genes in patients with no family history and apparent drug-induced LQTS. One report suggested that such variants may be present in as many as 10 to 15 percent of patients with drug-induced LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link&amp;anchor=H11#H11\">",
"     \"Acquired long QT syndrome\", section on 'Mutations in LQTS genes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Clinical course",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical course varies according to whether or not the patient is treated and with age, sex, and genotype.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Untreated versus treated patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic untreated patients with LQTS are at high risk of SCD. Reports from the 1970s and 1980s estimated the mortality rate to be as high as 20 percent at one year and 50 to 60 percent at 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subsequent reports have described a lower mortality rate, primarily because of medical treatment. In the Pediatric Electrophysiology Society study, the incidence of SCD at five years was 8 percent (1.6 percent per year); predictors of SCD included the length of the QTc at presentation and medication noncompliance [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/17\">",
"     17",
"    </a>",
"    ]. A lower rate of mortality was also noted in the International Long-QT Syndrome Registry; at an average follow-up of 54 months, the mortality rate was 0.9 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since treated patients have a different risk from untreated patients, determining the true natural history of LQTS from a registry population (which includes many treated patients) is difficult. The best data come from reports analyzing first cardiac events, since patients who had not previously experienced an event were likely to be untreated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Genotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical course of LQTS is influenced by the specific genotype (",
"    <a class=\"graphic graphic_table graphicRef58937 \" href=\"UTD.htm?42/34/43565\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link\">",
"     \"Genetics of congenital and acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Analyses of the correlation between genotype and cardiac risk have been performed using patients from the International Registry who have undergone genotyping. In initial reports, risks for children under age 15 were as follows (",
"    <a class=\"graphic graphic_figure graphicRef75990 \" href=\"UTD.htm?36/10/37038\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/42\">",
"     42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In LQT1, the risk of a cardiac event (syncope, SCD, or cardiac arrest) was greater between the ages of 5 and 15 than before age 5",
"     </li>",
"     <li>",
"      In LQT2, the highest risk occurred between the ages of 10 and 15",
"     </li>",
"     <li>",
"      In LQT3, cardiac events were infrequent before the age of 10 and were also less common than in LQT1 and LQT2",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    By age 40 years, the cumulative event rate was much lower in LQT3 than in LQT1 or LQT2 (18 versus 63 and 46 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/42\">",
"     42",
"    </a>",
"    ]. However, the cumulative mortality rate by age 40 years (3 to 4 percent) was similar regardless of genotype, indicating that the lethality of cardiac events was greater in families with LQTS 3 compared to LQT1 or LQT2 (20 versus 4 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A subsequent analysis from the International Registry suggested a more complex relationship between genotype and risk that also is dependent upon sex and QTc [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/43\">",
"     43",
"    </a>",
"    ]. This report suggested that the previous study had been biased by the inclusion of patients from a relatively small number of families (541 members of 38 families). The new analysis, which included 647 members of 193 families, identified three strata of risk according to the probability of experiencing a first cardiac event before age 40 in untreated patients:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      High risk (&ge;50 percent) &ndash; patients with QTc &ge;0.50 sec who have LQT1 or LQT2 or (if male) LQT3",
"     </li>",
"     <li>",
"      Intermediate risk (30 to 49 percent) &ndash; female patients with LQT3 and QTc &ge;0.50 sec or patients with QTc &lt;0.50 sec who have LQT3 or (if female) LQT2",
"     </li>",
"     <li>",
"      Low risk (&lt;30 percent) &ndash; patients with QTc &lt;0.50 sec who have LQT1 or (if male) LQT2",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical features of LQTS are also affected by the specific mutation within a given genotype. This was illustrated in an analysis of 37 families with LQT1 mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/44\">",
"     44",
"    </a>",
"    ]. Of these, 27 had mutations in the transmembrane region of KCNQ1 and 10 had mutations in the C-terminal region. Family members with transmembrane mutations appeared to have a higher risk defect as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      They were more likely to have a diagnostic ECG (82 versus 24 percent)",
"     </li>",
"     <li>",
"      They had more QT prolongation with exercise (QTc 0.57 versus 0.47 sec)",
"     </li>",
"     <li>",
"      They were more likely to have a cardiac event (syncope, aborted cardiac arrest, or sudden cardiac death) (55 versus 21 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2157420\">",
"    <span class=\"h3\">",
"     Age and sex",
"    </span>",
"    &nbsp;&mdash;&nbsp;Age and sex influence the clinical course. In reports from the International Registry, at least one cardiac event occurred in 50 percent of probands (first identified family members) by age 12 years and 90 percent by age 50 (",
"    <a class=\"graphic graphic_figure graphicRef68308 \" href=\"UTD.htm?37/37/38493\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/18\">",
"     18",
"    </a>",
"    ]. Although the majority of probands (71 percent) and affected family members (62 percent) with gene mutations were females [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/45\">",
"     45",
"    </a>",
"    ], males tended to have their initial symptomatic event at an earlier age than females (eight versus 14 years) despite similar degrees of QT prolongation (",
"    <a class=\"graphic graphic_figure graphicRef68308 \" href=\"UTD.htm?37/37/38493\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. The risk of experiencing a first cardiac event was higher in males until puberty and higher in females during adulthood. By age 15, 74 percent of males but only 51 percent of females had had a first cardiac event; by age 40, the comparable figures were equivalent at 83 and 86 percent.",
"   </p>",
"   <p>",
"    It has been postulated that gonadal hormone effects may mediate age and sex related differences in clinical course as well as increases in risk in women with LQT2 genotype during pregnancy and menopause [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Influence of pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women with LQTS (particularly those with LQT2 mutation), the risk of VT is especially high in the postpartum period. The effect of pregnancy in women with LQTS is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/31/7674?source=see_link&amp;anchor=H18809430#H18809430\">",
"     \"Ventricular arrhythmias during pregnancy\", section on 'Long QT syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2156296\">",
"    <span class=\"h3\">",
"     Influence of menopause",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increased risk of recurrent syncope has also been observed after the onset of menopause among women with the LQT2 mutation (hazard ratio 3.38 during the transition to menopause and 8.10 during the postmenopausal period) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/47\">",
"     47",
"    </a>",
"    ]. In contrast the onset of menopause was associated with a reduction in risk of recurrent syncope among women with the LQT1 genotype (hazard ratio 0.19).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Family members",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first-degree relatives of probands should have a lower incidence of SCD than the probands, since not all first-degree relatives will have inherited the responsible disease gene. However, even relatives who have a prolonged QT interval (and thus might be presumed to have LQTS clinically) are at lower risk of cardiac events (",
"    <a class=\"graphic graphic_figure graphicRef68308 \" href=\"UTD.htm?37/37/38493\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/45,48,49\">",
"     45,48,49",
"    </a>",
"    ]. Reports on family members (who by definition did not have an early event that would have made them a proband) from the International Registry included the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A QTc &gt;0.44 sec was seen in 50 percent of family members; 10 percent had a QTc &gt;0.50. The QTc was a strong and significant predictor of a cardiac event. The odds ratio was 2.18 when the QTc was &gt;0.44 to &le;0.46 sec, 3.93 when the QTc was &gt;0.46 to &le;0.50 sec, and 9.66 when the QTc was &gt;0.50 sec.",
"     </li>",
"     <li>",
"      By age 40, cardiac events (syncope, SCD, or cardiac arrest) occurred in 17 percent of family members overall, and in 26 percent of those with a prolonged QT interval. First-degree relatives had a higher incidence of cardiac events by age 40 than second-degree relatives (26 versus 10 percent).",
"     </li>",
"     <li>",
"      The clinical severity of the LQTS of the proband (QTc interval, age at first cardiac event) did not predict the clinical severity of the LQTS syndrome in parents or siblings [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The risk of experiencing a first cardiac event by age 15 was slightly higher among male than female family members (20 versus 16 percent). By age 40, the comparable figures were 24 and 28 percent.",
"     </li>",
"     <li>",
"      The overall rate of both first and subsequent cardiac events was similar for male and female family members during the first 18 years of life. Adult women had higher event rates than adult men (20 versus 13 percent). These figures may reflect the fact that the mean QTc was comparable for males and females through age 15 (0.442 versus 0.441 sec), but then decreased for males but not females (0.429 versus 0.447 sec).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     ASSOCIATED CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of specific clinical conditions in children are associated with LQTS. These warrant ECG screening and occasionally further evaluation for LQTS. Although the majority of LQTS cases occur without associated noncardiac syndromic features, recognition of these phenotypic associations may allow presymptomatic identification of LQTS patients. This would permit early treatment to prevent potentially life-threatening arrhythmic events.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Congenital sensorineural deafness",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Jervell and Lange-Nielsen syndrome refers to the autosomal recessive phenotype of congenital LQTS that is associated with profound sensorineural hearing loss and a high risk for sudden death. This was illustrated in a series of 186 patients compiled from both literature review and referrals [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/10\">",
"     10",
"    </a>",
"    ]. The following features were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      QTc was markedly prolonged (557 msec)",
"     </li>",
"     <li>",
"      Cardiac events occurred in 86 percent of the cohort, 95 percent of events were triggered by emotional or physical stress",
"     </li>",
"     <li>",
"      SCD rates were &gt;25 percent",
"     </li>",
"     <li>",
"      Clinical manifestations are present early in life, with event rates of 15, 50, and 90 percent by ages 1, 3, and 18",
"     </li>",
"     <li>",
"      High rates of symptoms and SCD persisted on beta blocker therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Referral bias may have contributed to these very high event rates, but the young age at onset of symptoms and the poor response medical therapy suggest the need to consider aggressive therapy in these patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26682?source=see_link\">",
"     \"Prognosis and management of congenital long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In Norway, where the Jervell and Lange-Nielsen syndrome was first described, the prevalence is at least one in 200,000.",
"   </p>",
"   <p>",
"    The Jervell and Lange-Nielsen syndrome has only been identified in patients with mutations in KVLQT1 (LQT1) or KCNE1 (LQT5); these genes encode the alpha and beta subunits of the slowly acting component of the outward-rectifying potassium current (IKs) that is involved in ventricular repolarization (",
"    <a class=\"graphic graphic_table graphicRef58937 \" href=\"UTD.htm?42/34/43565\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/9,50,51\">",
"     9,50,51",
"    </a>",
"    ]. Both homozygotes (two abnormal alleles of the same gene) and compound heterozygotes (two different mutations) have been described. These mutations also disrupt production of endolymph in the stria vascularis in the cochlea, resulting in deafness [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency of LQTS in children with congenital deafness ranges from 0.28 to 3.7 percent, as illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a report from Turkey, five of 132 deaf-mute children (3.7 percent) had QTc intervals &gt;0.44 sec and had a high or intermediate probability of LQTS based on Schwartz criteria scores [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/53\">",
"       53",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=see_link&amp;anchor=H16#H16\">",
"       \"Diagnosis of congenital long QT syndrome\", section on 'LQTS score'",
"      </a>",
"      .) The remaining 127 children had subtle abnormalities in repolarization and T wave dispersion that were significantly different from age-matched controls. The clinical significance of this observation is unknown. A lower incidence of LQTS (0.6 percent) was noted in another report from Turkey of 350 children [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In data compiled from 10 reports, 14 of 5077 deaf-mute individuals (0.28 percent) had LQTS [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon these findings, we recommend that an ECG be performed to detect LQTS in all children with congenital sensorineural deafness. Since the Jervell and Lange-Nielsen syndrome is typically more severe than Romano-Ward type LQTS, the sensitivity of a single ECG is probably higher for identification of LQTS. However, the statistical comparison of a single screening ECG versus serial ECGs for diagnostic accuracy in Jervell and Lange-Nielsen syndrome has not been assessed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Sudden infant death syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some cases of sudden infant death syndrome (SIDS) may be caused by LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/55-60\">",
"     55-60",
"    </a>",
"    ]. The frequency with which this might occur has been evaluated in large studies of screening ECGs of newborns [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/55\">",
"     55",
"    </a>",
"    ] and in genetic analyses of series of SIDS cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/58,59\">",
"     58,59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a prospective study, ECGs were recorded on the third or fourth day after birth in 34,442 newborns who were then followed for one year [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/55\">",
"     55",
"    </a>",
"    ]. Among the 34 deaths in the cohort, 24 were classified as SIDS. The QTc was significantly longer in the infants who died from SIDS compared to the survivors and those who died from other causes (0.435 versus 0.400 and 0.393 sec). The QTc was &ge;0.44 sec in 12 of the 24 SIDS infants but none of the others. The odds ratio for SIDS in infants with a QTc &ge;0.44 sec was 41.3 (95% CI 17.3-98.4).",
"   </p>",
"   <p>",
"    The parents of these children had apparently normal ECGs suggesting that, if congenital LQTS were responsible, it was due to either a spontaneous mutation or a mutation of low penetrance. A subsequent report from the same investigators described an infant resuscitated from SIDS who had persistent QT interval prolongation and a mutation in the gene encoding the sodium channel SCN5A that is affected in LQT3 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/56\">",
"     56",
"    </a>",
"    ]. This represented a spontaneous mutation since neither parent had the mutation and both had a QT interval within normal limits. A spontaneous mutation in SCN5A was also noted in another infant [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency with which congenital LQTS might be responsible for SIDS has also been evaluated through genetic testing.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a report of 93 SIDS cases in which postmortem mutation analysis was performed, two (2.2 percent) had mutations in the SCN5A gene [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 201 SIDS cases, postmortem molecular screening of seven genes associated with LQTS found mutations and genetic variants that were likely contributors to SIDS in 19 cases (9.5 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/59\">",
"       59",
"      </a>",
"      ]. Thirteen of these cases were associated with one of nine distinct abnormalities in the SCN5A gene [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon this association, routine neonatal ECG screening has been proposed to identify infants with LQTS. However, this approach has not been widely endorsed for several reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/61\">",
"     61",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The low incidence of SIDS means that the positive predictive value of an abnormal neonatal ECG is only about 1.5 percent, ie, 98.5 percent of positive screening studies will prove to be false positives.",
"     </li>",
"     <li>",
"      The QTc criteria used in one of the above newborn studies [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/55\">",
"       55",
"      </a>",
"      ] would label 2.5 percent of healthy infants as having a \"prolonged\" QTc interval, subjecting",
"      <span class=\"nowrap\">",
"       patients/care-givers",
"      </span>",
"      to additional testing and psychological stress.",
"     </li>",
"     <li>",
"      Other problems include the multifactorial nature of SIDS and the unknown effectiveness of primary prevention [",
"      <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37194?source=see_link\">",
"     \"Sudden infant death syndrome: Risk factors and risk reduction strategies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, universal newborn ECG screening is costly, and its benefit depends upon the underlying mechanism of SIDS and the effectiveness of monitoring and antiarrhythmic treatment. It has been estimated that the cost of universal ECG screening in the United States is over $18,000 per additional life year gained, assuming that preventive therapy would be effective in all identified cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/62\">",
"     62",
"    </a>",
"    ]. If therapy prevented less than 10 percent of SIDS cases, the cost would be much higher ($119,000 per life year gained).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Andersen syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Andersen syndrome, also known as Andersen-Tawil syndrome or hypokalemic periodic paralysis with cardiac arrhythmia, is a rare autosomal dominant disorder characterized by episodes of paralysis, ventricular arrhythmias, and dysmorphic features [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/63\">",
"     63",
"    </a>",
"    ]. Subsequent genetic studies identified this disorder as LQT7 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Andersen syndrome, which is distinct from other forms of periodic paralysis, is caused by mutations in the gene KCNJ2, located on chromosome 17q23, which encodes the inward rectifying potassium channel Kir2.1 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. These mutations appear to prolong the terminal phase of the myocardial action potential and, in the presence of low extracellular potassium, can induce Na-Ca exchanger-dependent delayed afterpotentials [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link&amp;anchor=H12#H12\">",
"     \"Genetics of congenital and acquired long QT syndrome\", section on 'LQT type 7'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Affected patients usually present in childhood with spontaneous attacks of paralysis, which may be associated with low, normal or elevated potassium levels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9193?source=see_link&amp;anchor=H14#H14\">",
"     \"Hypokalemic periodic paralysis\", section on 'Andersen syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The characteristic phenotype of Andersen syndrome includes short stature, hypertelorism, a broad nose, low-set ears, and a hypoplastic mandible [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/66\">",
"     66",
"    </a>",
"    ]. In one report of 36 individuals, the frequency of clinical features was as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/64\">",
"     64",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dysmorphic features &ndash; 78 percent",
"     </li>",
"     <li>",
"      Prolonged QT interval &ndash; 71 percent",
"     </li>",
"     <li>",
"      Ventricular arrhythmias &ndash; 64 percent",
"     </li>",
"     <li>",
"      Periodic paralysis &ndash; 64 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At least two of these abnormalities were present in 29 (81 percent). Although polymorphic VT was a common arrhythmia, deterioration into a hemodynamically compromising rhythm or ventricular fibrillation was rare.",
"   </p>",
"   <p>",
"    Characteristic T-U wave morphologies have also been identified in patients with Andersen syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/67\">",
"     67",
"    </a>",
"    ]. The ECG features were initially characterized in a series of 39 patients with genetically confirmed LQT7 and phenotypic Andersen syndrome, and then validated in a series of 147 individuals (57 with LQT7, 61 unaffected family members, and 29 with phenotypic features of Andersen syndrome, but negative for LQT7). The following abnormalities were identified by visual inspection:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prolonged terminal T wave downslope",
"     </li>",
"     <li>",
"      Biphasic U waves in limb leads",
"     </li>",
"     <li>",
"      Wide T-U junction, in contrast to bifid T waves in LQT2",
"     </li>",
"     <li>",
"      Enlarged U waves",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment of Andersen syndrome is complicated because of the opposing effects of potassium replacement on the QT interval and on skeletal muscle weakness. Elevation of the serum potassium concentration shortens the QT interval and suppresses ventricular arrhythmias, but worsens skeletal muscle weakness.",
"   </p>",
"   <p>",
"    Patients with hypokalemic periodic paralysis should have a screening ECG to detect QT interval prolongation. The diagnosis of Andersen syndrome should be considered in patients with LQTS and characteristic phenotypic features.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Syndactyly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with LQTS and syndactyly have been described in two case reports of five patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/9/2202/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. Four of the children also had patent ductus arteriosus. The lack of a family history of LQTS suggested that the disorder resulted from spontaneous new mutations.",
"   </p>",
"   <p>",
"    These children all developed transient 2:1 atrioventricular block, probably as a consequence of prolonged ventricular repolarization rather than an intrinsic conduction abnormality. Four of the five children died suddenly at a young age.",
"   </p>",
"   <p>",
"    Although the prevalence of this association is not known, children with syndactyly should have a screening ECG to detect QT prolongation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/25/19859?source=see_link\">",
"       \"Patient information: Long QT syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The long QT syndrome (LQTS) is an inherited disorder of myocardial repolarization characterized by a prolonged QT interval on the electrocardiogram (ECG) (",
"      <a class=\"graphic graphic_waveform graphicRef77018 \" href=\"UTD.htm?26/24/27008\">",
"       waveform 1",
"      </a>",
"      ) and an increased risk of sudden cardiac death associated with an increased risk of life-threatening ventricular arrhythmias, most commonly torsades de pointes degenerating into ventricular fibrillation (",
"      <a class=\"graphic graphic_waveform graphicRef53891 graphicRef73827 \" href=\"UTD.htm?3/40/3719\">",
"       waveform 2A-B",
"      </a>",
"      ). The primary symptoms in patients with LQTS include palpitations, syncope, seizures, and cardiac arrest. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mutations in at least 12 genes have been identified thus far in patients with genetic LQTS; the distinct genetic types are designated LQT1 through LQT12 (",
"      <a class=\"graphic graphic_table graphicRef58937 \" href=\"UTD.htm?42/34/43565\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two clinical phenotypes have been described in congenital LQTS that differ in the type of inheritance and the presence or absence of sensorineural hearing loss (see",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The more common autosomal dominant form, the Romano-Ward syndrome, has a purely cardiac phenotype. It can result from any of the mutations found thus far in congenital LQTS or other as yet unidentified mutations.",
"     </li>",
"     <li>",
"      The autosomal recessive form, the Jervell and Lange-Nielsen syndrome, is associated with LQTS and sensorineural deafness, and a more malignant clinical course. It has been described only in LQT1 and LQT5, both of which affect the slowly acting component of the outward-rectifying potassium current (IKs). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Congenital sensorineural deafness'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In addition to symptomatic presentations, asymptomatic patients with LQTS may also be identified because they have an affected family member or a prolonged QT interval corrected for heart rate (QTc) identified on an ECG performed for other indications. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Arrhythmias in patients with congenital LQTS include torsade de pointes, which may be associated with bradycardia and atrioventricular block. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Types of arrhythmia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Causes of acquired LQTS, such as drugs, hypokalemia, and hypomagnesemia (",
"      <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"       table 2",
"      </a>",
"      ) also can precipitate ventricular arrhythmia in patients with congenital LQTS. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Acquired LQTS'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"       \"Acquired long QT syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Conditions associated with LQTS include congenital sensorineural deafness (Jervell and Lange-Nielsen syndrome), sudden infant death syndrome, Andersen syndrome, and syndactyly. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Associated conditions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/1\">",
"      Moss AJ. Long QT Syndrome. JAMA 2003; 289:2041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/2\">",
"      Li H, Fuentes-Garcia J, Towbin JA. Current concepts in long QT syndrome. Pediatr Cardiol 2000; 21:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/3\">",
"      Jackman WM, Friday KJ, Anderson JL, et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988; 31:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/4\">",
"      El-Sherif N, Turitto G. Torsade de pointes. Curr Opin Cardiol 2003; 18:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/5\">",
"      Passman R, Kadish A. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. Med Clin North Am 2001; 85:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/6\">",
"      Khan IA. Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med 2002; 112:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/7\">",
"      Wehrens XH, Vos MA, Doevendans PA, Wellens HJ. Novel insights in the congenital long QT syndrome. Ann Intern Med 2002; 137:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/8\">",
"      Camm AJ, Janse MJ, Roden DM, et al. Congenital and acquired long QT syndrome. Eur Heart J 2000; 21:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/9\">",
"      Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 2000; 36:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/10\">",
"      Schwartz PJ, Spazzolini C, Crotti L, et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 2006; 113:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/11\">",
"      Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J 2000; 21:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/12\">",
"      Vincent GM. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Annu Rev Med 1998; 49:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/13\">",
"      Schwartz PJ. The long QT syndrome. Curr Probl Cardiol 1997; 22:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/14\">",
"      Quaglini S, Rognoni C, Spazzolini C, et al. Cost-effectiveness of neonatal ECG screening for the long QT syndrome. Eur Heart J 2006; 27:1824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/15\">",
"      Napolitano C, Priori SG, Schwartz PJ, et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005; 294:2975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/16\">",
"      Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 1992; 327:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/17\">",
"      Garson A Jr, Dick M 2nd, Fournier A, et al. The long QT syndrome in children. An international study of 287 patients. Circulation 1993; 87:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/18\">",
"      Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991; 84:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/19\">",
"      Pacia SV, Devinsky O, Luciano DJ, Vazquez B. The prolonged QT syndrome presenting as epilepsy: a report of two cases and literature review. Neurology 1994; 44:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/20\">",
"      Pfammatter JP, Donati F, D&uuml;rig P, et al. Cardiac arrhythmias mimicking primary neurological disorders: a difficult diagnostic situation. Acta Paediatr 1995; 84:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/21\">",
"      Singh B, al Shahwan SA, Habbab MA, et al. Idiopathic long QT syndrome: asking the right question. Lancet 1993; 341:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/22\">",
"      Davis AM, Wilkinson JL. The long QT syndrome and seizures in childhood. J Paediatr Child Health 1998; 34:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/23\">",
"      Peeters CM, Wijnberger DE, Kamphuis DJ, et al. How reliable is asking the \"right question\" in diagnosing idiopathic long QT syndrome? Lancet 1995; 345:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/24\">",
"      Vincent GM. The heart rate of Romano-Ward syndrome patients. Am Heart J 1986; 112:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/25\">",
"      Beinder E, Grancay T, Men&eacute;ndez T, et al. Fetal sinus bradycardia and the long QT syndrome. Am J Obstet Gynecol 2001; 185:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/26\">",
"      Lupoglazoff JM, Denjoy I, Villain E, et al. Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations. J Am Coll Cardiol 2004; 43:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/27\">",
"      Mitchell JL, Cuneo BF, Etheridge SP, et al. Fetal heart rate predictors of long QT syndrome. Circulation 2012; 126:2688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/28\">",
"      Veldkamp MW, Wilders R, Baartscheer A, et al. Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families. Circ Res 2003; 92:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/29\">",
"      Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/30\">",
"      Wilde AA, Jongbloed RJ, Doevendans PA, et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol 1999; 33:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/31\">",
"      Moss AJ, Robinson JL, Gessman L, et al. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol 1999; 84:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/32\">",
"      Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000; 102:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/33\">",
"      Takenaka K, Ai T, Shimizu W, et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003; 107:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/34\">",
"      Ackerman MJ, Tester DJ, Porter CJ. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc 1999; 74:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/35\">",
"      Batra AS, Silka MJ. Mechanism of sudden cardiac arrest while swimming in a child with the prolonged QT syndrome. J Pediatr 2002; 141:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/36\">",
"      Choi G, Kopplin LJ, Tester DJ, et al. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation 2004; 110:2119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/37\">",
"      Ali RH, Zareba W, Moss AJ, et al. Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol 2000; 85:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/38\">",
"      Tan HL, Bardai A, Shimizu W, et al. Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications. Circulation 2006; 114:2096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/39\">",
"      Yang P, Kanki H, Drolet B, et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002; 105:1943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/40\">",
"      Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J 1985; 109:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/41\">",
"      Schwartz PJ, Periti M, Malliani A. The long Q-T syndrome. Am Heart J 1975; 89:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/42\">",
"      Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998; 339:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/43\">",
"      Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003; 348:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/44\">",
"      Shimizu W, Horie M, Ohno S, et al. Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. J Am Coll Cardiol 2004; 44:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/45\">",
"      Locati EH, Zareba W, Moss AJ, et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 1998; 97:2237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/46\">",
"      Zareba W, Moss AJ. Long QT syndrome in children. J Electrocardiol 2001; 34 Suppl:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/47\">",
"      Buber J, Mathew J, Moss AJ, et al. Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2. Circulation 2011; 123:2784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/48\">",
"      Zareba W, Moss AJ, le Cessie S, et al. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol 1995; 26:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/49\">",
"      Kimbrough J, Moss AJ, Zareba W, et al. Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation 2001; 104:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/50\">",
"      Duggal P, Vesely MR, Wattanasirichaigoon D, et al. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. Circulation 1998; 97:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/51\">",
"      Huang L, Bitner-Glindzicz M, Tranebjaerg L, Tinker A. A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res 2001; 51:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/52\">",
"      Tranebjaerg L, Bathen J, Tyson J, Bitner-Glindzicz M. Jervell and Lange-Nielsen syndrome: a Norwegian perspective. Am J Med Genet 1999; 89:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/53\">",
"      Tuncer C, Cokkeser Y, Komsuoglu B, et al. Assessment of ventricular repolarization in deaf-mute children. Pediatr Cardiol 2000; 21:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/54\">",
"      Ocal B, Imamoglu A, Atalay S, Ercan Tutar H. Prevalence of idiopathic long QT syndrome in children with congenital deafness. Pediatr Cardiol 1997; 18:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/55\">",
"      Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998; 338:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/56\">",
"      Schwartz PJ, Priori SG, Dumaine R, et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 2000; 343:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/57\">",
"      Wedekind H, Smits JP, Schulze-Bahr E, et al. De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 2001; 104:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/58\">",
"      Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 2001; 286:2264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/59\">",
"      Arnestad M, Crotti L, Rognum TO, et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 2007; 115:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/60\">",
"      Wang DW, Desai RR, Crotti L, et al. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 2007; 115:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/61\">",
"      Guntheroth WG, Spiers PS. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998; 339:1161; author reply 1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/62\">",
"      Zupancic JA, Triedman JK, Alexander M, et al. Cost-effectiveness and implications of newborn screening for prolongation of QT interval for the prevention of sudden infant death syndrome. J Pediatr 2000; 136:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/63\">",
"      Andersen ED, Krasilnikoff PA, Overvad H. Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? Acta Paediatr Scand 1971; 60:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/64\">",
"      Tristani-Firouzi M, Jensen JL, Donaldson MR, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002; 110:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/65\">",
"      Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001; 105:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/66\">",
"      Sansone V, Griggs RC, Meola G, et al. Andersen's syndrome: a distinct periodic paralysis. Ann Neurol 1997; 42:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/67\">",
"      Zhang L, Benson DW, Tristani-Firouzi M, et al. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation 2005; 111:2720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/68\">",
"      Marks ML, Whisler SL, Clericuzio C, Keating M. A new form of long QT syndrome associated with syndactyly. J Am Coll Cardiol 1995; 25:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/9/2202/abstract/69\">",
"      Marks ML, Trippel DL, Keating MT. Long QT syndrome associated with syndactyly identified in females. Am J Cardiol 1995; 76:744.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1036 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-192C8F5B95-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2202=[""].join("\n");
var outline_f2_9_2202=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34850992\">",
"      - Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Types of arrhythmia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Torsades de pointes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Bradycardia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - AV block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Triggers of arrhythmia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34850781\">",
"      - External triggers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Pause dependence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Influence of genotype",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Acquired LQTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Clinical course",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Untreated versus treated patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Genotype",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2157420\">",
"      - Age and sex",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Influence of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2156296\">",
"      - Influence of menopause",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Family members",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      ASSOCIATED CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Congenital sensorineural deafness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Sudden infant death syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Andersen syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Syndactyly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1036\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1036|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/27/9662\" title=\"figure 1\">",
"      Trigger event vs LQTS genotype",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/10/37038\" title=\"figure 2\">",
"      Long QT genotype outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/37/38493\" title=\"figure 3\">",
"      Cardiac events LQTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1036|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/34/43565\" title=\"table 1\">",
"      Long-QT syndrome genes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/48/2830\" title=\"table 2\">",
"      Causes of long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1036|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?26/24/27008\" title=\"waveform 1\">",
"      Prolonged QT interval tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/23/43380\" title=\"waveform 2A\">",
"      ECG Torsades de pointes tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/7/43134\" title=\"waveform 2B\">",
"      ECG torsades de pointes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37641?source=related_link\">",
"      Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=related_link\">",
"      Diagnosis of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=related_link\">",
"      Genetics of congenital and acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9193?source=related_link\">",
"      Hypokalemic periodic paralysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38422?source=related_link\">",
"      Myocardial action potential and action of antiarrhythmic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/25/19859?source=related_link\">",
"      Patient information: Long QT syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26682?source=related_link\">",
"      Prognosis and management of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37194?source=related_link\">",
"      Sudden infant death syndrome: Risk factors and risk reduction strategies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/31/7674?source=related_link\">",
"      Ventricular arrhythmias during pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_9_2203="Examples of agoraphobic behaviors";
var content_f2_9_2203=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F58076&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F58076&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Examples of agoraphobic safety behaviors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Travelling with a familiar person",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carrying a cell phone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carrying medication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carrying a water bottle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sitting close to an exit or a door",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Taking a medication prophylactically (eg, anti-diarrheal or anti-nauseant)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carrying a paper bag (in case of hyperventilation)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2203=[""].join("\n");
var outline_f2_9_2203=null;
var title_f2_9_2204="ABS guidelines prost brachyther";
var content_f2_9_2204=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F50303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F50303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    American Brachytherapy Society criteria for permanent brachytherapy of the prostate: contraindications",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Clinical exclusion criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Life expectancy &lt;5 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Large or poorly healed TURP defect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unacceptable operative risks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Distant metastases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Relative",
"contraindications for brachytherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        These patients are not ideal candidates for brachytherapy, but have nevertheless been successfully implanted. Beginners",
"should not implant these patients.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Patients",
"at increased risk of developing complications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Large median lobes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Previous pelvic irradiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        High AUA score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        History of multiple pelvic surgeries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Severe diabetes with healing problems",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Technical",
"difficulties which may result in inadequate dose coverage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Previous TURP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Gland size &gt;60 cc at time of",
"implantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prominent median lobe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Positive seminal vesicles",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TURP: transurethral resection of the prostate; AUA: American Urological Association.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Int J Radiat Oncol Biol Phys 1999; 44:790.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2204=[""].join("\n");
var outline_f2_9_2204=null;
var title_f2_9_2205="Indication contraind LVRS";
var content_f2_9_2205=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69501&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69501&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Potential indications and contraindications for LVRS",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Parameter",
"      </td>",
"      <td class=\"subtitle1\">",
"       Indications",
"      </td>",
"      <td class=\"subtitle1\">",
"       Contraindications",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"4\">",
"       Clinical",
"      </td>",
"      <td>",
"       Age &lt;75 years",
"      </td>",
"      <td>",
"       Age &ge;75 years",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ex-smoker (&gt;6 months)",
"      </td>",
"      <td>",
"       Current smoking",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Clinical picture consistent with emphysema",
"      </td>",
"      <td>",
"       Surgical constraints (eg, previous thoracic procedure, pleurodesis, chest wall deformity)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dyspnea despite maximal medical therapy and pulmonary rehabilitation",
"      </td>",
"      <td>",
"       Pulmonary hypertension (PA systolic &gt;45 mmHg, PA mean &gt;35 mmHg)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"5\">",
"       Comorbid illness*",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Clinically significant bronchiectasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Clinically significant coronary heart disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Heart failure with an ejection fraction &lt;45 percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Uncontrolled hypertension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Obesity&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"4\">",
"       Physiology",
"      </td>",
"      <td>",
"       FEV1 after bronchodilator &lt;45 percent predicted",
"      </td>",
"      <td>",
"       FEV1 &le;20 percent predicted with either DLCO &le;20 percent predicted or homogeneous emphysema",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hyperinflation (TLC &gt;100 percent predicted, RV &gt;150 percent)",
"      </td>",
"      <td>",
"       PaO2 &le;45 mmHg on room air",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Post rehabilitation 6-minute walk distance &gt;140 meters",
"      </td>",
"      <td>",
"       PaCO2 &ge;60 mmHg",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Low post rehabilitation maximal achieved cycle ergometry watts&Delta;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"4\">",
"       Imaging",
"      </td>",
"      <td>",
"       Chest radiograph - hyperinflation",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       HRCT confirming severe emphysema, ideally with upper lobe predominance",
"      </td>",
"      <td>",
"       Homogeneous emphysema with FEV1 &le;20 percent predicted",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Significant pleural or interstitial changes on HRCT",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Nonupper lobe predominant emphysema and high post rehabilitation maximal achieved cycle ergometry watts&loz;",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FEV1: forced expiratory volume in one second; TLC: total lung capacity; RV: residual volume; PaO2: arterial partial pressure of oxygen; PaCO2: arterial partial pressure of carbon dioxide; HRCT: high resolution computed tomography.",
"     <br>",
"      * Comorbid illnesses may be considered relative contraindications depending on degree of severity.",
"      <br>",
"       &bull; The NETT trial required a body mass index less than 31.1 kg/m2 for men and less than 32.3 kg/m2 for women. It is not known whether more severe obesity would adversely affect perioperative risk.",
"       <br>",
"        &Delta; Low post rehabilitation maximal achieved cycle ergometry watts (W) is defined as at or below the sex specific 40th percentile (25 W for women and 40 W for men).",
"        <br>",
"         &loz; High post rehabilitation maximal achieved cycle ergometry watts (W) is defined as above the sex specific 40th percentile (25 W for women and 40 W for men). This is a relative contraindication.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: www.thoracic.org/COPD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2205=[""].join("\n");
var outline_f2_9_2205=null;
var title_f2_9_2206="Flexible cylindrical diffuser";
var content_f2_9_2206=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F81291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F81291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flexible cylindrical diffuser",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 231px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light exits through the rigid tip laterally in a cylindrical fashion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Armin Ernst, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2206=[""].join("\n");
var outline_f2_9_2206=null;
var title_f2_9_2207="Pertussis by age group US";
var content_f2_9_2207=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F67295&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F67295&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 556px\">",
"   <div class=\"ttl\">",
"    Reported pertussis incidence by age group 1990-2011",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 536px; height: 371px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Centers for Disease Control and Prevention, National Notifiable Diseases Surveillance System, 2011. Available at",
"     <a href=\"file://www.cdc.gov/pertussis/surv-reporting.html\" style=\"font-style: italic;\" target=\"_blank\">",
"      www.cdc.gov/pertussis/surv-reporting.html",
"     </a>",
"     (Accessed on January 29, 2013).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_9_2207=[""].join("\n");
var outline_f2_9_2207=null;
